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ABSTRACT 
Self-Assembling Peptide Hydrogels Targeted For Dental Tissue Regeneration 
by 
Kerstin Martina Galler 
Dental caries and traumatic impact are two major causes of destruction of dental soft and 
mineralized tissues that affect a large segment of the population and pose major public 
health concerns. Conventional treatment strategies rely on mere replacement with bioinert 
filling materials. Hence, a critical need exists for biology-based therapeutic approaches to 
restore damaged dental tissues to their original form and function. Recent developments in 
tissue engineering, material sciences and stem cell research offer considerable potential to 
impact dental therapies. A customized scaffolding system laden with bioactive factors could 
deliver dental stem cells to the site of injury. An applicable scaffold should be biocompatible 
and biodegradable, accommodate cells, incorporate growth and differentiation factors, and 
allow for injection into small defects. Synthetic peptide hydrogels are particularly 
interesting in all these aspects. Our pilot study demonstrated their compatibility with two 
dental stem cell lines. In Specific Aim 1, peptide sequences were developed to further 
optimize the system for cell proliferation and spreading. In Specific Aim 2, the gels were 
modified to incorporate bioactive molecules and growth factors for cell differentiation and 
vasculogenesis. Release profiles were established, and cell culture studies demonstrated the 
induction of cellular differentiation. For Specific Aim 3, the generated material was utilized 
in an animal model, where constructs of cell- and growth-factor-laden gels in standardized 
dentin cylinders were transplanted into immunocompromised mice. Soft connective tissue 
formation and new blood vessel formation could be observed, along with localized collagen 
deposits, indicating beginning dentin formation. In summary, the objective of this research 
was to modify and optimize peptide-based hydrogels in order to develop a novel tissue 
engineering approach for the regeneration of dental tissues. 
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CHAPTER I: INTRODUCTION 
1. Teeth: Development, Structure and Function, Pathology 
Teeth serve important functions of mastication, phonation and speech; dentition shapes 
our smiles and facial expressions and imparts uniqueness to individuals. This might be 
reason enough to strive for novel treatment strategies and advance from replacement to 
true regeneration of damaged or missing teeth. However, beyond the obvious, teeth exhibit 
several features well worth a closer look. Although small, they come in different shapes and 
sizes. Humans have a succedaneous dentition and a complex eruption pattern that 
determines the order in which permanent teeth follow their deciduous predecessors. Each 
tooth is a complex structure composed of several distinct soft and mineralized tissues of 
unique architectural characteristics and different functions. The hard tissues enclosing the 
pulp are classic composite materials. Ordinarily brittle, inorganic hydroxyapatite is re-
enforced by organic components, which determine the respective material properties. 
Figure 1: Anatomy of the tooth. 
1: enamel; 2: dentin; 3: dental pulp; 4: gingiva; 5: alveolar bone; 
6: periodontal ligament; 7: root dentin; 8: cementum. 
Adapted from [1]. 
Enamel covers the tooth crown that is visible in the oral cavity and 
consists almost exclusively of inorganic hydroxyapatite. It is a 
ceramic-like material and the hardest substance found in our body 
due to a high mineral content that is supported by a small percentage of unique non-
collagenous proteins. The underlying dentin which makes up the bulk of the tooth has a 
composition similar to bone but possesses a different and unique tubular structure. 
Collagen fibers serve as a template for mineral deposition and provide elasticity, and dentin 
supports the brittle outer layer of enamel. The dental pulp is enclosed in a chamber in the 
core of the tooth and is made of fibroblasts, nerves, blood and lymph vessels, and soft 
connective tissue. Highly specialized dentin-forming odontoblasts line the pulp chamber, 
and they secrete a collagenous matrix called predentin, which later mineralizes. As the 
production of dentin progresses, each odontoblast leaves a cellular process behind, 
j i t . <.'4tiM' •- '<•'. 
l i p * » ' % '.'•-•'^ '•- •-
iPi ••A-T.;,•••-••:•• embedded in a single dentinal tubule. The intimate 
association between dentin and the odontoblasts that is 
established during development continues through the life 
of a tooth. Hence the structure of dentin maintains tooth 
vitality by communicating various pathologic and 
biomechanical signals to the underlying pulp. 
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Figure 2: Histological image of the dentin-pulp complex. A layer of odontoblasts secretes 
the predentin matrix, which later mineralizes. Primary dentin is formed during tooth 
development, secondary dentin throughout our lifetime. Adapted from [2]. 
The root dentin is covered with yet another species of mineralized tissue, the 
cementum. Tendon-like fibers insert both into the cementum and the surrounding alveolar 
bone, thus anchoring the tooth in its socket. This periodontal ligament is important for 
proprioception and cushions large forces during mastication. 
The complex architecture of teeth and a unique structural composition provides 
durability for a lifetime. Teeth can withstand enormous abrasive forces, large temperature 
changes, varying pH and a moist and corrosive environment. Despite their strength, teeth 
3 
are susceptible to damage caused by bacterial infection, chemicals or mechanical trauma. A 
common cause for the loss of hard tissues in teeth is dental caries, a degradative disease 
process fuelled by sugars in the diet and cariogenic microorganisms. Over time, these oral 
bacteria deposit complex biofilms on the tooth's surface. Their metabolites create an acidic 
environment, resulting in demineralization of the inorganic matrices and cavitation, 
progressing from the enamel to the dentin. Subsequently, bacterial toxins can enter the 
pulp chamber and cause inflammation and degeneration of the underlying soft tissue. 
continues, it reaches the 
underlying dentin. At this stage, bacterial toxins can diffuse through the dentinal tubules 
and cause an inflammatory reaction in the pulp (B, C). Further demineralization leads to 
exposure of the pulp, bacterial invasion, necrosis of the pulp tissue and migration of bacteria 
into the surrounding bone via the apical dental foramen. Adapted from [3]. 
During therapeutic intervention, infected enamel or dentin can be removed and 
replaced with an inert filling material, thus maintaining vitality and function of the dental 
pulp. In the face of ongoing insult, necrosis ensues and the tissue has to be removed 
completely. 
Besides caries, erosion can lead to destruction of dental enamel or dentin; 
furthermore fractures after traumatic impact. If the dental pulp is exposed after loss of 
dental hard tissues, contamination and necrosis of the soft tissue follow, and the 
inflammatory process can spread into the surrounding bone, oftentimes resulting in tooth 
loss. 
4 
2. Current Treatment Methods 
To date, treatment strategies rely on the insertion of synthetic materials such as metal 
alloys, ceramics, cements and composite resins to restore defects in enamel and dentin. An 
interesting aspect is that the use of malleable or carved materials for tooth replacement 
reaches far back in human history, and thus dentists were among the first to apply material 
science in a biological setting. 
Amalgam, a mixture alloy of mercury and at least one other metal, used to be the 
golden standard for dental restorations. Recently, it has been exchanged for highly 
sophisticated materials such as dental resin composites, which settle esthetic claims and 
aim at high quality material properties. Over the last decades, companies have invested 
heavily in the development and improvement of dental materials, involving research efforts 
of mainly chemists and material scientist. 
Detected early, infected enamel or dentin can be removed and replaced with a filling 
material, thus maintaining vitality and function of the dental pulp. Even after exposure of 
the pulpal tissue, regeneration is still possible. Application of calcium hydroxide or mineral 
trioxide as a pulp capping material stimulates defense mechanisms and reparative dentin 
formation. Despite these advances, problems remain. In composite filling materials, 
marginal gaps often form due to polymerization shrinkage, which leads to tensile stress 
between the cavity wall and the restoration. These gaps facilitate the invasion of bacteria 
and bacterial products into the dentinal tubules and the dental pulp, leading to post-
operative sensitivity, secondary caries and pulpal damage [4]. If intervention comes too 
late, necrosis of the soft tissue ensues. After loss of the dental pulp, thorough debridement, 
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disinfection and subsequent obturation of the pulp chamber and root canal system are 
necessary to prevent reoccurrence of infection. While root canal fillings have been utilized 
as replacements for decades and show high success rates of over 90% over 8 years [5], they 
fail to restore physiological form and function of lost tissues and are incapable of 
remodeling and repair as a response to ongoing stimulation or injury. 
The loss of dental pulp after traumatic impact poses another serious problem to 
patients and dentists. The incidence of tooth fracture, mainly of the incisors, is highest in 
children and young adults [6] and is associated with considerable challenges since root 
formation is not complete until 3 years after the tooth has fully erupted. After complicated 
tooth fractures with exposure of the soft tissue in immature teeth, bacterial contamination 
leads to inflammation and subsequent tissue necrosis, and root formation comes to a halt 
as the mineralizing cells are lost. If the condition is not treated, the inflammation will spread 
into the surrounding alveolar bone and eventually the tooth will be lost. Treatment with 
calcium hydroxide or mineral trioxide aggregate (MTA) can induce a continuation of hard 
tissue formation in the apical region. In order to control infection, calcium hydroxide, for 
example, has to be applied frequently over a prolonged period of time of 5 to 20 months 
[7]. The procedure is often complicated by divergent root canals, making debridement 
difficult. Failure to control infection can result in root resorption, apical radiolucencies or 
root fracture, and eventually tooth loss [6]. This, in turn, leads to an arrest of bone 
development in that area of the dental arch, as the teeth transmit load into the bone and 
thus trigger bone and jaw growth and remodeling. Insertion of a dental titanium implant 
covered with a ceramic crown, which can substitute for a lost tooth, might be severely 
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complicated if the bone in the area of supposed implantation is underdeveloped and thin, 
requiring alveolar bone augmentation before an implant can be placed. Furthermore, 
implantation is considered only after growth is completed and is usually not performed 
before the age of 18. 
Overall, restoration of lost tooth tissue, whether from disease or trauma, represents 
a significant proportion of the daily routine for practicing clinicians. The 2003 WHO World 
Oral Health Report [8] as well as a recent follow-up [9] identified oral diseases as a major 
and continuing public health problem. This is based on their impact in terms of pain, 
impairment of function and thus effect on quality of life along with their high prevalence 
and global incidence. Treatment costs are estimated as accounting for 5-10% of the 
healthcare budget in industrialized countries, leaving us with a daunting challenge to 
minimize the burden of restoring teeth. 
3. Regenerative Dentistry 
Regenerative dentistry strives for the development of innovative treatment strategies which 
lead to true regeneration rather than replacement and repair. Two distinct approaches can 
be distinguished to achieve this goal: whole tooth regeneration and the regeneration of 
partial tooth structures. 
In order to engineer a whole tooth, researchers are investigating events occurring 
during tooth development. Tooth formation is initiated and progresses through cross talk 
and reciprocal interactions between two morphologically different tissues from different 
germ layers, the ectoderm and the underlying mesenchyme. Understanding the molecular 
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mechanisms responsible for these events is not only interesting to developmental 
biologists, but is key for tissue engineers who aim to reiterate these processes in vitro in 
order to regenerate a whole biotooth [10]. This biology-based strategy provides a viable 
alternative to the use of today's state-of-the-art titanium implant. 
Whereas replacement of whole teeth remains a challenge, regeneration of partial 
tooth structures might be a more achievable short-term goal. In general, newly developed 
dental biomaterials have not capitalized on the intrinsic regenerative capacity of oral 
tissues. Such natural resources could be taken advantage of for more biologically-driven 
treatment strategies. Formation of new dentin and partial regeneration of periodontal 
ligament can be stimulated through therapeutic intervention. In either case, the healing 
process is thought to involve the recruitment of uncommitted progenitors or stem cells, 
which hold the capacity to differentiate and produce the respective matrices to repair and 
restore damaged tissues. The recent isolation of postnatal stem cells from a variety of oral 
tissues marks a milestone in regenerative dentistry, and these cells provide a promising tool 
for future treatment strategies. On the other hand, tissue engineering scaffolds are 
transitioning from passive cell delivery systems to bioactive matrices, which allow for 
incorporation of biomolecules and can thus elicit a desired cellular response. The 
combination of dental stem cells with novel scaffolding materials might enable us to 
engineer oral tissues in the near future. 
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4. Tissue Engineering 
Tissue engineering is an emerging interdisciplinary field that integrates principles of 
developmental, cellular and molecular biology, genetics, medicine, chemistry, material 
sciences and engineering. The term was first coined in 1985, and defined as "the application 
of principles of engineering and life sciences toward fundamental understanding of 
structure-function relationships in normal and pathological mammalian tissues, and the 
development of biological substitutes to restore, maintain or improve tissue functions" [11]. 
The emergence of the field has resulted from the need for tissue and organ replacements 
[12]. Significant progress has been made over the last decades in understanding and 
harnessing those structure-function relationships, and tissue-engineered products are 
already commercially available and used for novel and improved treatment methods in 
medicine. 
The concept of tissue engineering is based on the combination of the following: (1) 
ex-vivo expanded (stem) cells, (2) a biocompatible carrier or scaffold material and (3) 
bioactive molecules to induce cellular differentiation and tissue formation. Thus, tissue 
engineering strategies utilize the functional triad of cells, scaffold and biomolecules to 
recapitulate physiological processes of development and regeneration. This important 
challenge presents itself to biologists and bioengineers, chemists and material scientists 
who must design biomimetic and bioactive scaffolds to drive the field forward. 
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4.1. Stem Cells 
The most valuable cells for regenerative medicine are stem cells. These cells possess the 
capability for self-renewal and can differentiate into various lineages, a characteristic called 
plasticity. Stem cells are commonly defined as either 'embryonic' or 'postnatal' [13]. Stem 
cells are also subdivided into pluripotent and multipotent categories according to their 
plasticity. Embryonic stem cells, which are comprised in the inner cell mass of the blastocyst 
(5-14 days after conception), are pluripotent, which means each cell can form any cell type 
of the body. However, the use of embryonic tissues is afflicted with legal and ethical issues. 
The recent creation of "induced pluripotent stem cells" (iPS) by re-programming somatic 
cells to re-activate characteristics of embryonic stem cells set a new milestone and promises 
to revolutionize regenerative medicine [14, 15]. 
In contrast, postnatal stem cells possess a limited capability to differentiate but can 
still form a number of lineages and are readily accessible. Mesenchymal stem cells, which 
have commonly been isolated from bone marrow, give rise to osteoblasts, chondrocytes, 
myocytes, adipocytes, neuronal cells, or beta-pancreatic islets cells, any pathway can be 
induced by addition of adequate cell culture supplements or differentiation factors. Many 
researchers focus on postnatal stem cells in order to bypass the legal and ethical issues 
associated with embryonic stem cells. In fact, postnatal stem cells are a promising tool as an 
alternative source for clinical applications, both in regards to their accessibility and lack of 
immunogenicity, despite their reduced plasticity. 
Postnatal stem cells have been successfully utilized for bone marrow transplants for 
certain types of cancer [16], injection into heart muscle after infarction to produce 
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cardiomyocytes [17], re-growth of damaged neuronal axons [18], bone and cartilage 
regeneration [19, 20], or skin and vascular grafts [21, 22]. Recently, postnatal stem cells 
have been isolated from tissues such as umbilical cord, peripheral blood or adipose tissue. 
Today, stem cells can be isolated from various sources, including the oral cavity. 
4.1.1. Tooth-Derived Mesenchymal Stem Cells 
A long-standing obstacle in regenerative dental medicine is to obtain progenitor cells that 
will continually divide and produce cells or tissues suitable for implantation in the oral 
cavity. Cells could either come from an allogenic source, e.g. as a disease- and pathogen-
free human pulp stem cell line, or from the same patient as autologous stem cells from oral 
tissues, such as mucosa or dental pulp. The latter might cause constraints, since expansion 
of sufficient cell numbers could be time-consuming, regarding the fact that many adult 
tissues contain only 1-4% stem cells [23]. 
Since dentin-producing odontoblasts are terminally differentiated, postmitotic cells, 
they cannot proliferate to replace lost cells after injury. The ability of both young and old 
teeth to respond to injury by induction of reparative dentinogenesis suggests that a small 
population of competent progenitor pulp stem cells may exist within the dental pulp 
throughout life. For many years, possible sources of replacement cells had been discussed 
controversially. Progenitor cells were thought to reside in the cell-rich zone subjacent to the 
odontoblast layer, in the core of the pulp as undifferentiated mesenchymal cells, or in the 
perivascular niche [24]. Today, several different sources of dental stem cells have been 
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identified. Stem cells can be isolated from mixed cell populations by four commonly used 
techniques: 
1) Fluorescence activated cell sorting (FACS) using a flow cytometer, 
2) Immuno-magnetic bead selection, 
3) Immuno-histochemical staining, 
4) Physiological and histological criteria including phenotype, chemotaxis, proliferation, 
differentiation and mineralizing activity. 
4.1.2. Dental Pulp Stem Cells 
Teeth are an easily accessible source to harvest postnatal stem cells from different tissues, 
including dental pulp, periodontal ligament, or dental follicle and apical papilla of 
developing teeth. The most applicable for our approach are stem cells derived from dental 
pulp. Gronthos et al. first isolated stem cells from the pulp of developing third molars, DPSC 
(dental gulp stem cells). These cells are highly proliferative, differentiate into various 
lineages, and are able to form dentin-pulp-like complexes, but not lamellar bone, after 
transplantation in vivo [25, 26]. Three years later, Miura et al. were able to harvest 
clonogenic cells from exfoliated deciduous teeth, SHED (stem cells from h_uman exfoliated 
deciduous teeth), and differentiated them into odontoblasts, adipocytes or neural cells [27]. 
Interestingly, both SHED and DPSC are located in the perivascular niche, they express the 
mesenchymal stem cell marker STRO-1 and the pericyte marker CD146 [28]. 
However, SHED are considered distinct from DPSC for several reasons. Compared to 
DPSC or bone marrow stromal stem cells (BMSSC), SHED display increased numbers of 
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population doublings and higher proliferation rates [27]. Although both cell types show 
calcium accumulation after osteogenic induction in vitro, DPSC cells are able to form dense 
mineralized nodules, indicating a higher potential to mineralize. After transplantation in 
vivo, SHED develop into odontoblast-like cells associated with a dentin-like structure, but 
are unable to regenerate a complete dentin-pulp complex as observed with DPSC. On the 
other hand, SHED show a strong osteoinductive capacity and promote host cell 
differentiation into bone-forming cells [25, 27]. The behavior of these cells reflects their 
physiological function in vivo. Deciduous teeth are significantly different from permanent 
teeth with regards to their development, tissue structure and function. Whereas pulp cells 
in deciduous teeth fail to generate new dentin after injury, this can commonly be observed 
in adult pulp. Due to the strong osteoinductive capacity of SHED it has been suggested that 
these cells not only guide the eruption of permanent teeth, but furthermore induce bone 
formation during the eruption process [27]. SHED therefore represent a population of stem 
cells that might be more immature and is distinct from DPSC with respect to their higher 
proliferation rates, increased population doublings, sphere-like cluster formation, 
osteoinductive capacity and a failure to reconstitute a dentin-pulp like complex in vivo. 
Both dental stem cell lines have been demonstrated to retain their multipotential 
differentiation ability after cryopreservation [29, 30]. SHED and DPSC used in studies 
described in this dissertation were kindly provided by Dr. Songtao Shi at USC. 
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4.2. Scaffolds 
In order to provide a three-dimensional microenvironment to accommodate cells and guide 
their adhesion, growth and subsequent differentiation, we are in need of suitable 
scaffolding systems. In one scenario, cells can be seeded onto the scaffold and cultured in 
vitro to generate the desired tissue before transplantation. A slightly different approach is 
the design of materials for transplantation of a primarily cell-free system, which will, due to 
a combination of signaling molecules incorporated in the scaffold, induce the homing of 
stem cells residing in the respective tissues, and promote their differentiation to support 
regeneration. Cell-free biocompatible scaffolds are especially attractive because of an easier 
handling process that eliminates the issues associated with the use of stem cells and their 
expansion in vitro, with storage and shelf-life, cost aspects, immunoresponse of the host 
and transmission of diseases. 
In any case, an ideal scaffold material has to be non-toxic, biocompatible and non-
immunogenic to avert any damage to neighboring cells. The scaffold should be degradable 
by enzymes or hydrolysis at a rate that allows for replacement with newly formed tissue. As 
a carrier for drugs and differentiation factors, the material should be versatile enough to 
enable the incorporation and controlled release of bioactive molecules. 
A variety of materials has been designed and constructed for tissue engineering 
approaches, namely natural and synthetic polymers or inorganic materials and composites, 
which have been fabricated into porous scaffolds, nanofibrous materials, microparticles and 
hydrogels. 
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Natural materials include collagen, elastin, fibrin, alginate, silk, glycosaminoglycans 
such as hyaluronan, and chitosan. They offer a high degree of structural strength, are 
biocompatible and biodegradable, but are often difficult to process and afflicted with the 
risk of transmitting animal-associated pathogens or provoking an immunoresponse. 
Collagen has been of special interest and has been used for manifold tissue engineering 
approaches in bone and tooth tissue engineering; it has been fabricated as gels, nanofibers, 
porous scaffolds and films. However, it is mechanically weak and undergoes rapid 
degradation [31]. 
Synthetic polymers on the other hand provide excellent chemical and mechanical 
properties and allow for high control over the physicochemical characteristics, such as 
molecular weight, configuration of polymer chains, or the presence of functional groups. 
Disadvantages of synthetic polymers can be a chronic or acute inflammatory host response, 
and localized pH decrease due to relative acidity of hydrolytically degraded byproducts. 
Commonly used synthetic scaffolds are fabricated from poly lactic acid (PLLA), poly glycolic 
acid (PGA), and their copolymer, poly lactic-co-glycolic acid (PLGA). PLLA is a very strong 
polymer and has found many applications where structural strength is important. PGA has 
been used as an artificial scaffold for cell transplantation, and degrades as the cells excrete 
extracellular matrix. Both PLLA and PGA are nontoxic and biocompatible; they degrade by 
simple hydrolysis and have gained FDA approval for a number of applications [32, 33]. 
Hydrogels made from collagen, poly ethylene glycol, fibrin, glycosaminoglycans or 
self-assembling peptide molecules have recently been explored for tissue engineering 
applications in more detail. They offer numerous interesting properties including high 
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biocompatibility, a tissue-like water content, viscoelastic properties similar to soft tissues, 
efficient transport of nutrients and metabolic products, uniform cell encapsulation, and the 
possibility of injection and gelation in situ. Based on their chemistry, they can be chemically 
or physically crosslinked, and modifications such as incorporation of biofunctional 
molecules or growth and differentiation factors are possible [34, 35]. In our laboratory, we 
focus on hydrogel systems made from short peptide building blocks, and the development 
of a peptide-based scaffold conducive for dental stem cell proliferation and differentiation 
was the objective for Specific Aim 1 of this research. 
4.2.1. Peptide-Based Hydrogels 
The ECM network, which is the physiological microenvironment of cells, is mainly composed 
of fibrillar proteins; their construction as a well-organized matrix is achieved though self-
assembly. In order to provide optimized matrices for tissue engineering approaches, novel 
materials are required to generate supramolecular structures which resemble natural ECM 
and display biological functions. Self-assembly is a process that is mediated by non-covalent 
weak chemical bonds, namely ionic bonds, hydrogen bonding, hydrophobic interactions or 
van der Waals interactions. In the past decade, many synthetic self-assembling peptides 
have been developed for tissue engineering approaches [36 - 41]. Typically, they are 8-16 
amino acids long and contain alternating hydrophilic and hydrophobic residues. Hydrophilic 
modules consist of alternatively repeating units of positively charged amino acids, such as 
lysine or arginine, and negatively charged aspartic or glutamic acid. The peptides form 
stable 6-sheets in water, but upon exposure to physiological salt concentration or pH they 
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self-assemble into nanofiber networks, which form self-supporting gels with a water 
content of more than 99%. Self-assembling peptides can be synthesized by solid phase 
chemistry, but are also commercially available, such as RAD16-I peptides (Puramatrix). A 
slightly different concept is used for peptide amphiphile (PA) molecules, where a peptide 
segment is coupled to a fatty acid chain. The process of self-assembly is driven by formation 
of a hydrophobic core composed of closely packed alkyl tails, fibrous strands can build 
because of hydrogen bond formation between the amino acids of adjacent PA molecules. 
Whereas the PAs remain amorphous aggregates at neutral pH due to the repulsive negative 
charge which prevents self-assembly, addition of polyvalent ions eliminates the negative 
net charge and allows self-assembly into cylindrical micelles, which undergo physical 
crosslinking to provide the gelled macrostructure. Self-assembly can be triggered by mixture 
of PA solutions with cell culture media or other physiological fluids that contain polyvalent 
metal ions. 
It has been shown that cells can move, proliferate and differentiate within the 
hydrogel [39, 40, 42, 43]. The compatibility of self-assembling peptides with cells may be 
related to the size of the fibers. Most biopolymers used for tissue engineering have fiber 
sizes ranging from 10 to 100 u.m, which is similar to the size of most mammalian cells. 
Essentially, cells grow in these polymers on a curved two-dimensional surface. In contrast, 
self-assembling peptides form nanofibers of 6-20 nm in diameter, which mimics the 
structure of extracellular matrix, allowing true three-dimensional cell culture. Cells can bind 
to self-assembling peptides with their adhesion molecules, but the size of the nanofibers 
does not inhibit interaction with other cells in all three dimensions [44]. 
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Another advantage of self-assembling peptides is the extreme flexibility with which 
they can be designed and modified, following a modular conception. The molecules can be 
functionalized by adding adhesion motifs, such as RGD, enzyme-cleavable sites, or heparin-
binding domains to tether growth factors, such as vascular endothelial growth factor (VEGF) 
or fibroblast growth factor 2 (FGF2). Optimization for specific cell types and targeting 
towards defined applications are possible. Immunohistochemical analysis after injection of 
self-assembling peptides in vivo did not show obvious inflammation or immune response 
[45 -47 ] . 
4.2.2. Multidomain Peptides 
Recently, a peptide architecture was developed in our laboratory that undergoes self-
assembly in water to form short nanofibers [48]. The peptide molecules are designed to 
display distinct regions of function or "domains" arranged in an ABA block motif, and they 
self-assemble into nanofibers which feature similarity to the make-up of natural ECM. The 
process of supramolecular assembly is driven by a core motif (B) of alternating hydrophilic 
(glutamine or serine) and hydrophobic (leucine) amino acid residues. In an aqueous 
environment, the side groups segregate to opposing sides of the backbone, and two peptide 
molecules form a sandwich upon hydrophobic packing between leucine residues. The fiber 
elongate as the dimers string together and hydrogen bonding occurs along the fiber axis. 
Charged amino acid residues in the flanking region (A) provide water solubility, but 
counteract fiber assembly via electrostatic repulsion and can thus be utilized to control fiber 
length [48]. However, addition of multivalent ions screens the charge and results in physical 
18 
crosslinking, fiber elongation, entrapment of water and gelation. 
With a fiber diameter of 6 nm, hydrogels created from MDPs mimic the nanoscale 
dimensions and structure of natural ECM, where cells can bind to the fibers via adhesion 
molecules, but still interact with other cells [44]. True three-dimensional cell growth within 
the nanofibrous gels makes these materials promising candidates as scaffolds for cell 
delivery. Incorporation of bioactive sequences in either the central block or the flanking 
regions of MDPs can further enhance cell-matrix interactions and promote desired cellular 
responses. 
In Specific Aim 1 of this project, multidomain peptide hydrogels were modified and 
optimized for compatibility with dental stem cells. 
Figure 4. Chemical 
structure of peptide 
K2(QL)6K2. The three 
key regions that 
control the peptides' 
self-assembly into a 
nanostructured fiber 
are shown. The 
peptides making up 
these nanofibers have 
three key regions that control their assembly: 1) a hydrophobic face, which is the energetic 
driving force for self-assembly in water; 2) a hydrophilic face, which provides water solubility 
and opposition to region 1, creating a facial amphiphile; and 3) charged peripheral groups 
that limit the extent of self-assembly via electrostatic repulsion and also aid in solubility. 
Regions 1 and 2 are formed from a pattern of alternating hydrophobic and hydrophilic 
amino acids such that when the peptide is in a fully extended conformation, the amino acid 
side chains alternate between one side of the peptide and the other. This arrangement 





Region 3 Region 3 
Figure 5: Mechanism of nanofiber formation. The hydrophilic and hydrophobic amino acid 
residues assemble on either side of the peptide backbone to form a facial amphiphile. 
Hydrophobic packing occurs between leucine residues, and a hydrophobic sandwich forms 
(A). Model of nanofiber self-assembly, indicating the hydrophobic packing region, hydrogen 
bonding axis and repulsive positive charges (B). cryoTEM images of nanofibers before and 
after addition of phosphate, which eliminates the repulsive positive charges, resulting in 
increased fiber length and gelation (C). 
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4.3. Bioactive Molecules and Dental Stem Cell Differentiation 
Increased understanding of the biological processes mediating tissue repair has allowed 
some investigators to mimic or supplement tooth reparative responses. Dentin contains 
many proteins capable of stimulating these processes. Demineralization of the dental 
tissues can lead to the release of growth factors entrapped in the dentin matrix, following 
the application of cavity etching agents or restorative materials and even caries [49]. Once 
released, these growth factors may play key roles in signaling many of the events of 
reparative dentin formation [50, 51]. Growth factors, especially those of the transforming 
growth factor-beta (TGFB) family, are important in cellular signaling for differentiation and 
stimulation of dentin matrix secretion. These growth factors are secreted by dentin-forming 
cells during tooth development and deposited within the organic matrix preceding the 
mineralized tissue [52 - 54], where they remain protected in an active form through 
interaction with other components [55]. The addition of purified dentin protein fractions 
has stimulated an increase in dentin matrix secretion [56]. The TGFP superfamily of ligands 
furthermore includes another important group of growth factors in tooth development and 
regeneration, the bone morphogenetic proteins (BMP's). Recombinant human BMP-2 
stimulates differentiation of adult pulp stem cells into an odontoblast-like morphology in 
culture [57, 58]. Recombinant BMP-2, -4, and -7 induce formation of reparative dentin in 
vivo [57, 59]. Besides growth factors, other molecules have been shown to stimulate pulp 
cell differentiation. Dentin matrix protein-1, a non-collagenous protein involved in the 
mineralization process induced cytodifferentiation, collagen production and calcified 
deposits in dental pulp in a rat model [60]. Dexamethasone, a synthetic glucocorticoid, 
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reduced cell proliferation and induced expression of the differentiation markers alkaline 
phosphatase and dentin sialophosphoprotein in primary human pulp cells [61]. Addition of 
(3-glycerophosphate to the cell culture medium in explants from human teeth induced a 
change in cell morphology, collagen synthesis and mineral formation [62]. Whereas 
combinations of inorganic phosphate and dexamethasone are used as standard osteogenic 
supplements to drive differentiation of bone-forming osteoblasts, it has also been proven to 
induce dental stem cell differentiation followed by mineral deposition [26, 27]. This may be 
explained by the fact that osteogenesis and dentinogenesis are highly similar processes, and 
osteoblasts and odontoblasts are closely related cell lineages. However, they remain distinct 
cell types, as observed by their slightly different gene expression profile and the structural 
differences of their respective products, bone and dentin. Optimal conditions permissive for 
dental stem cell differentiation into odontoblasts rather than osteoblasts remain to be 
elucidated. 
The increasing knowledge about these biological processes enables us to develop 
materials which go beyond the basic requirements of biocompatibility. Whereas in the past, 
biomaterials were designed to be bioinert as not to damage the tissues around the 
implantation site, we are now striving to make scaffolding systems bioactive, where 
incorporation of growth factors or other drugs actively stimulate a desired response. For 
Specific Aim 2 of this project, we started customizing multidomain peptide hydrogels by 
incorporation of growth factors and bioactive molecules relevant for dental stem cell 
differentiation and tissue formation. 
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4.4. Engineering of Partial Tooth Structures 
Several groups have begun to develop strategies to engineer dental pulp. In 1996, a pulp-
like tissue was first engineered in vitro after seeding pulp fibroblasts on PGA scaffolds, 
where cells formed new tissue after 60 days in culture [63]. Using a similar approach, the 
ability of different scaffold materials to support pulp tissue formation from pulp fibroblasts 
was evaluated two years later. PGA, collagen hydrogels and alginate were tested. Culturing 
cells on PGA resulted in tissue formation and collagen synthesis, whereas only moderate 
cell proliferation was observed on collagen and no proliferation on alginate [64]. 
Recently, formation of pulpal tissue could be demonstrated in vivo. Dental stem cells 
were seeded on PLLA scaffolds and inserted into the pulp cavity of tooth slices after 
removal of the original tissue. These constructs were implanted subcutaneously into 
immunodeficient mice. It could be shown that dental stem cells differentiate into 
odontoblast-like cells, and that the resulting 
tissues contained newly formed blood 
vessels [65]. Mobilization and release of 
growth factors and proteins from the dentin 
A ' # 
.,-_.A•.•9JST *£"•'' due to locally decreased pH by degradation &:£':.• 
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-/»*.. ".V\.'..V% O f * - * differentiation process [65]. 
Figure 6: Engineering of dental pulp tissue. (A) Schematic of the strategy for dental pulp 
engineering. (B) Biodegradable scaffold prepared within the root canal and seeded with 
dental stem cells, subsequent subcutaneous implantation. (C) Scaffold-dentin interface. (D) 
Low magnification (lOOx) of a dental pulp engineered with dental pulp stem cells 14 days 
after implantation. (E) High magnification (400x) of the boxed area. Adapted from [65]. 
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In a similar approach, dentin cylinders were prepared from human teeth for Specific 
Aim 3, and hydrogels laden with dental stem cells and growth factors were implanted into 
immunocompromised mice to evaluate the potential of this system to form a tissue similar 
to dental pulp. 
CHAPTER II: PILOT STUDY 
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1. SHED in Peptide Amphiphile Hydrogels 
A detailed description of this work can be found in Appendix B, which contains a copy of the 
manuscript which was published in Tissue Engineering in 2008. The following paragraph 
provides a brief overview, whereas a thorough description of the material's chemistry, the 
methods used and the results obtained can be found in the paper. 
2. Introduction 
To establish general parameters for the compatibility of dental stem cells with peptide-
based hydrogels, a set of experiments was performed on a modification of peptide 
amphiphile (PA) hydrogel developed in our laboratory [66]. The structure of the molecules 
used in this study can be divided into four regions of function: the peptide sequence 
contains an MMP-2 specific enzyme-cleavable site to enable cell-mediated degradation; a 
glutamic acid to assist in calcium binding for self-assembly; and the cell adhesion motif 
RGDS. The fourth region of functionality is added after peptide synthesis by N-acylation with 
palmitic acid, which provides the driving force for self-assembly. Whereas the PAs remain 
amorphous aggregates at neutral pH due to the repulsive negative charge which prevents 
self-assembly, addition of divalent ions eliminates the negative net charge and allows self-
assembly into cylindrical micelles, which undergo physical crosslinking via calcium-ions to 
provide the gelled macrostructure. 
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In order to investigate the potential of peptide amphiphile hydrogels to 
accommodate dental stem cells, SHED and DPSC were seeded in peptide amphiphiles and 
cultured either with or without osteogenic supplements (0-control, P-glycerophosphate + 
dexamethasone, KH2P04 + dexamethasone). Cell proliferation and alkaline phosphatase 
activity were monitored via MTT and quantitative DNA and ALP assays. Real-time PCR 
experiments were performed using RNA extracted from SHED and DPSC after a four-week 
culture period with different osteogenic supplements. Marker genes of osteoblast and 
odontoblast differentiation were chosen to assess the differentiation potential of both cell 
lines in peptide amphiphiles under different culture conditions. The panel of genes included 
collagen a I (I) (Col I), collagen III (Col III), alkaline phosphatase (ALP), bone sialoprotein 
(Bsp), osteocalcin (Oc), Runx2 and dentin sialophosphoprotein (Dspp), which have been 
used as markers of mineralization and odontoblast differentiation before [27, 28, 67 - 69]. 
Besides the markers for cell differentiation, we included MMP-2, which is the main 
gelatinase secreted by human pulp cells [70], to assess whether proteinase activity was in 
accordance with cell proliferation and matrix degradation. A list of primer sequences for 
real-time PCR can be found in Appendix C. For histologic analysis, we stained with 
hematoxilin & eosin (H&E), Masson's trichrome and von Kossa to detect mineral deposition. 
3. Results and Discussion 
PA hydrogels were easy to handle, and continuous cell proliferation of SHED and DPSC was 
observed over a 4-week culture period. However, SHED proliferated at a higher rate 
compared to DPSC. Addition of p-GP + dex resulted in slightly increased proliferation rates 
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in both cell lines, whereas potassium phosphate + dex showed the opposite effect. 
Quantitative measurements of alkaline phosphatase activity showed a dramatic increase in 
alkaline phosphatase activity in both cell lines over time, but whereas SHED responded to 
treatment with 0GP + dex with a considerable increase in enzyme activity, DPSC showed a 
different profile, where potassium phosphate + dex evoked higher ALP levels. 
Gene expression studies of markers for osteoblast and odontoblast differentiation 
revealed increased expression except for dentin-specific Dspp, which ceased to be 
expressed in DPSC treated with potassium phosphate + dex. 0GP + dex appears to have a 
positive effect mainly on expression of extracellular matrix components (Col I, Col III), 
especially in SHED. At the same time, MMP-2 levels were increased. On the other hand, 
potassium phosphate + dex stimulated increased expression of genes typically found in the 
osteoblast lineages, which are involved in matrix mineralization, such as osteocalcin, bone 
sialoprotein and Runx2. 
Histologic analysis revealed degradation of the PA gel and replacement with 
extracellular matrix. Whereas SHED formed clusters of cells, DPSC were more sparsely 
distributed within the gel, they showed a round, osteoblast-like morphology, and a higher 
tendency of mineral deposition. CryoTEM images showed no mineral in gels without cells 
and gels with cells cultured without osteogenic supplements (0-control). Mineral can be 
seen in treated groups, to a higher degree in DPSC versus SHED, and higher with potassium 
phosphate + dex versus 3GP + dex. 
This data set provides evidence that the two stem cell lines are able to proliferate 
within the gel, to remodel it by enzymatic degradation and deposition of a collagenous 
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matrix, to change their morphology and gene expression profile as a sign of differentiation, 
and to induce calcium deposition and the formation of a mineralized matrix. 
4. Drawbacks 
Whereas PA hydrogels provide a suitable matrix for proliferation and differentiation of 
dental stem cells, a few drawbacks remain: 
1) The relatively rapid gelation of PAs (2-3 sec) might prevent thorough mixing and 
homogenous cell distribution within the gel. In-situ gelation of this material is 
possible, but a gel undergoing shear-recovery might be advantageous for in vivo 
applications. 
2) Addition of a fatty acid is necessary to induce self-assembly of PAs, which reduces 
the possibilities to add biofunctional ligands to one end of the molecule. 
The development of a system of self-assembling multidomain peptides (MDP) in our 
laboratory led to transition to MDP hydrogels for further work on this tissue engineering 
project. MDPs offered the opportunity of working with a novel, innovative and highly 
versatile system. The above mentioned drawbacks of PAs are not present in MDPs, and an 
iteration process of varying a parent MDP peptide sequence led us to the development of a 
customized peptide-based hydrogel system specifically targeted to for dental stem cells in 
an approach to engineer the dentin-pulp complex. 
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CHAPTER III: SPECIFIC AIMS 
1. Overview 
There are two major causes for the loss of mineralized matrices with subsequent loss of soft 
connective tissue in teeth. During cavity formation, demineralization of enamel and dentin 
allows for penetration of bacterial toxins to the dental pulp, causing inflammation and 
eventually tissue necrosis, leaving a devital tooth. Traumatic impact and tooth fracture lead 
to bacterial contamination and cause a similar situation. After loss of hard or soft tooth 
tissues, conventional treatment methods rely on replacement with biologically compatible 
materials alone. Amalgam, gold or resin composites are used to fill defects of the tooth 
crown. After necrosis of the dental pulp, debridement and obturation of the root canal and 
pulp chamber are necessary. 
However, the latest developments in the area of tissue engineering make it feasible 
to strive for biology-based approaches and true regeneration. Only recently, stem cell 
niches have been accessed, tooth-derived postnatal stem cells have been isolated, and their 
differentiation potential has been studied in vitro as well as after transplantation into 
immunocompromised animals. In order to utilize these cells for tissue engineering purposes 
in vivo, we are in need of suitable delivery systems. Novel technologies in scaffold design 
and synthesis make it possible to develop customized matrices, which will specifically 
promote proliferation and differentiation of dental stem cells to form and replace tooth 
tissues. An interesting class of biomaterials is peptide - based hydrogels. Following a 
bottom-up approach, peptide molecules can be designed to self-assemble into nanofibrous 
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networks highly similar to natural ECM, and form hydrogels. The system is highly versatile 
since peptide molecules can be designed following a modular concept and therefore be 
modified and optimized for specific applications. Bioactive peptide sequences and small 
molecule drugs can be incorporated in the peptide matrix, and living cells can be entrapped 
and cultured in the hydrogel. An injectable system is particularly interesting for application 
into small defects in the oral cavity. 
The overarching goal of this project was to explore future treatment strategies to 
preserve or regenerate a functional dentin-pulp complex. A synthetic, peptide-based 
scaffold should be optimized and customized for the growth and differentiation of dental 
stem cells for further applications in regenerative dentistry. The scaffold should 1) create an 
environment permissive for cell adhesion, proliferation and migration; 2) allow for cell-
mediated matrix degradation and remodeling; 3) stimulate new blood vessel formation via 
incorporation of vascular endothelial growth factor (VEGF); and 4) induce cell differentiation 
and mineralization through incorporation of growth or differentiation factors. 
2. Hypothesis 
Combining dental stem cells with a specifically modified peptide hydrogel might provide us 
with an applicable system to form the soft connective tissue for the regeneration of dental 
pulp. Directional cues for the cells can lead to deposition of new dentin, and thus formation 
of a functional dentin-pulp complex. Since dental pulp-derived stem cells have been 
demonstrated to differentiate into odontoblasts and form dentin after transplantation in 
vivo [26, 27], it seems most feasible to utilize these cells for our approach. DPSC (dental 
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gulp stem cells) are derived from dental pulp of extracted wisdom teeth; they possess 
multiiineage differentiation and are capable of forming dentin-pulp-like complexes after 
transplantation [25, 26]. SHED (stem cells from human exfoliated deciduous teeth) are 
derived from deciduous teeth after exfoliation, they show higher proliferation rates 
compared to DPSC, and present a more heterogeneous and immature cell population [27]. 
An optimized and customized peptide-based hydrogel should accommodate the cells in a 
three-dimensional environment for cell delivery. Incorporation of an adhesion sequence 
and an enzyme-cleavable site can result in cell attachment, cell-mediated degradation and 
cell migration through the synthetic matrix. Bioactive molecules and differentiation factors 
can stimulate new blood vessel formation and promote cell differentiation and subsequent 
tissue formation. Through an iteration process and synthesis of different peptides, an 
optimal sequence will be identified. The resulting hydrogels can be characterized regarding 
gel formation and handling aspects as well as mechanical properties. In vitro cell culture of 
dental stem cells with different peptide hydrogels can be used to assess cytocompatibility, 
cell proliferation rates, adhesion, spreading and migration as well as cell differentiation. For 
evaluation of this system in vivo, dentin cylinders will be a suitable carrier for the cell-laden 
hydrogels. Contact with the dentin walls will provide orientational cues to the cells and 
closely mimic a physiological situation. Transplantation of these constructs into a host will 
allow us to evaluate the system's potential to induce tissue formation, ideally production of 
the soft connective tissue of dental pulp and deposition of a dentin matrix in a directional 
manner towards the existing dentin. 
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3. Specific Aim 1 
To design and synthesize a peptide library in an iteration process to find an optimized 
sequence to accommodate dental stem cells and promote cell proliferation. 
The first part of this research project describes a rational process of design and synthesis of 
peptide sequences based on a parent peptide. Starting point is a 14 amino acid peptide, 
which undergoes self-assembly at physiological pH after addition of multivalent ions to form 
a hydrogel. The material is easy to handle, but does not provide sufficient gel strength. A 
step-by-step variation of this parent peptide is described, in which changes of single amino 
acids lead to a mechanically stronger gel, which furthermore features shear recovery. 
Incorporation of an enzyme-cleavable site and the cell adhesion motif arginine-glycine-
aspartic acid (RGD) improve cytocompatibility, which can be seen from cell proliferation 
rates in different gels, cell morphology and spreading as well as cell migration in the 
hydrogels. At the same time, rheological and chemical characterization of the peptides 
provides information about gel strength and degradation characteristics. Specific Aim 1 is 
completed after identification of a peptide sequence which fulfills the requirements in 
terms of optimized rheological and gelation properties for cell encapsulation, is 
cytocompatible and biodegradable, and allows for cell proliferation and spreading 
comparable to commercially available hydrogel systems. 
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4. Specific Aim 2 
To assess the potential of this system for cell differentiation after application of growth 
and differentiation factors. In a second step, bioactive factors are incorporated into 
peptide hydrogels, which will aid in cell differentiation and tissue formation. 
Biologically active compounds can be added to the media in cell culture, and the first part of 
this section shows the effect of combinations of differentiation factors on dental stem cells 
in monolayer or three-dimensional culture in peptide hydrogels. Evaluation of cell 
proliferation rates, expression of differentiation markers and matrix formation and 
mineralization provide information about lineage commitment and tissue formation. 
However, an in vivo application requires these molecules to be an integral part of 
the delivery system. Two bioactive factors, dexamethasone and 3-glycerophosphate, were 
incorporated into peptide hydrogels. Whereas dexamethasone loses its bioactivity after 
covalent linkage to peptide molecules, P-glycerophosphate induces gelation and aids in 
mineral formation in three-dimensional cultures. Furthermore, the peptide sequences can 
be designed such that heparin, a negatively charged glycosaminoglycan, stabilizes the self-
assembled nanofibers. At the same time, heparin can be used for binding and slow release 
of growth factors. This mechanism was utilized to incorporate vascular endothelial growth 
factor (VEGF), a potent stimulator of new blood vessel formation. Slowed release of VEGF 
from heparin-containing hydrogels is demonstrated. 
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5. Specific Aim 3 
To test the potential of the generated system for engineering of the dentin-pulp-complex 
in an appropriate animal model. 
The optimized peptide-hydrogel system laden with VEGF and 3-glycerophosphate was used 
as a carrier system for either SHED or DPSC cells. The gels were injected into small 
standardized dentin cylinders prepared from the roots of human molars. These constructs 
were transplanted subcutaneously into immunocompromised mice. After 2 and 5 weeks, 
the implants were harvested and examined for tissue formation in the dentin cylinders. 
Histological analysis revealed the formation of vascularized soft connective tissues inside 
the dentin cylinders for both cell lines. Immunohistochemistry allowed for the localization 
of microvessels. The presence of VEGF stimulated formation of significantly higher numbers 
of blood vessels compared to controls. Better nutrition in VEGF-containing gels in turn 
allowed for much improved cell growth and tissue formation. DPSC furthermore formed 
small and dense collagen deposits, and islands of cells dispersed throughout the tissue 
express dentin sialoprotein, a dentin-specific marker. 
Combination of the dental stem cells in this customized hydrogel system promoted 
vasculogenesis and formation of a soft connective tissue with localized matrix deposits. 
These results indicate that we have an applicable system for the regeneration of dental pulp 
at hand; however, directional deposition of dentin remains to be resolved. 
34 
CHAPTER IV: SPECIFIC AIM 1 
To design and synthesize a library of peptide sequences in an iteration process to find an 
optimized sequence to accommodate dental stem cells and promote cell proliferation. 
1. Summary 
Control over fiber length, various mechanisms for physical crosslinking, resemblance to 
natural ECM, versatility, biocompatibility and biodegradability along with the possibility to 
incorporate additional bioactive motifs for a custom-made scaffold make hydrogels 
assembled from multidomain peptides (MDPs) promising candidates for cell encapsulation 
and further use in tissue engineering [48, 71]. However, our first generation peptide 
architecture, the parent E(QL)6E (for peptide molecules see Table 1, for amino acid 
nomenclature and properties see Appendix A), had to undergo an optimization process to 
develop a sequence with a set of desired properties, which could accommodate dental stem 
cells. Therefore, a library of peptide sequences was designed, synthesized, characterized 
and tested for compatibility with dental stem cells during an iteration process. Specifically, 
the peptide should 
1) incorporate the cell adhesion motif RGD, 
2) contain an enzyme-cleavable site to enable cell-mediated degradation and cell migration, 
3) offer sufficient viscoelastic properties (storage modulus > 100 Pa), and 
4) form a matrix conducive for dental stem cell viability and proliferation. 
Cell adhesion, the first step of cell-matrix interaction, can be mediated by a variety 
of short peptide sequences, which can be incorporated into bioscaffolds to mimic ligands on 
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molecules abundant in natural ECM. The most common sequence incorporated into tissue 
engineering scaffolds is the integrin-binding tripeptide RGD, which was first detected in 
fibronectin [72]. Presentation of RGD in combination with another site, PHSRN, in close 
proximity mimicking their distance in fibronectin results in a synergistic effect and enhances 
cell spreading [73]. Therefore, the first step of optimization was to modify the parent 
peptide with RGD or a combination of RGD and PHSRN in the flanking region. Proliferation 
rates of dental stem cells were higher in these modified peptides compared to the parent 
peptide, indicating that this was a step in the right direction. However, we did not observe 
an improvement after addition of PHSRN, and decided to continue our work by attaching 
RGD only. 
Although conducive for cell proliferation, the hydrogels formed from E(QL)6E were 
mechanically weak and therefore difficult to handle. Alternative sequences were designed, 
and exchange of glutamine (Q) with serine (S) in the central block turned out to improve the 
mechanical properties of the gels substantially. The resulting E2(SL)6E2 and its counterpart 
K2(SL)5K2 were then modified to carry RGD in their flanking regions. Cell proliferation assays 
confirmed that the presence of the adhesion motif resulted in increased cell numbers. 
Biodegradability was another important feature to be incorporated into our 
hydrogels. The organization of MDP molecules into 3-sheet aggregates with poor water 
solubility and a fiber assembly process reminiscent of amyloid raises concerns that the 
material cannot be degraded in vivo and might not be suitable as a tissue engineering 
scaffold. This is underscored by the devastating effects of amyloid aggregates in brain, 
causing Alzheimer's disease and dementia, or other organs such as heart, kidney and the 
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vascular system. By programming susceptibility to proteolytic degradation into these B-
sheet forming peptides, MDPs can be adapted to requirements for biological applications. 
Based on the peptide K2(SL)6K2, a hexapeptide containing the MMP-2 consensus cleavage 
motif LRG [74] was incorporated into the central block. To confirm that modification 
resulted in susceptibility to degradation, a weight loss study was conducted and loss of gel 
mass over time after incubation with the enzyme was monitored. Furthermore, 
disintegration of the peptide molecules and the nanofibrous network was confirmed by 
mass spectrometry and cryoTEM, respectively. 
The mechanical properties of the hydrogels from all the sequences designed and 
synthesized were analyzed by oscillatory stress sweep rheometry. Based on experience and 
handling aspects, e.g. for the gels to withstand a series of processing steps for histologic 
analysis, sufficient gel strength for our application was defined for gels with a storage 
modulus (G') of > 100 Pa. 
In order to test for compatibility with dental stem cells, proliferation rates were 
assessed in hydrogels prepared from the different peptide sequences in comparison to two 
commercially available hydrogel systems. Cell morphology and spreading were observed by 
confocal microscopy to visualize the effect of different matrix chemistries on cellular 
behavior. For hydrogels prepared from peptides with enzyme-cleavable site, a cell migration 
study was conducted, where cells were seeded on top of the hydrogels, and migration of 
cells into the matrix was observed. 
At this point, we considered the iteration process completed. The peptide 
K(SL)3RG(SL)3KGRGDS, which features both the cell adhesion motif and an enzyme-cleavable 
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site, provided the most suitable environment to accommodate dental stem cells, resulting 
in cell proliferation rates comparable to commercially available systems, and allowing for 
cell spreading and migration into the hydrogel matrix. 
2. Peptide Design 
The following table gives an overview of all sequences synthesized during the course of this 
Ph.D. The mechanism of crosslinking is indicated, and a brief summary of the material 
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Table 1: Peptide Library. For single-letter amino acid code see Appendix A. 
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The original parent multidomain peptide E(QL)6E (MDP1) was modified to contain the cell 
adhesion motif G-RGD-S (MDP 1A) or a combination of both G-RGD-S and G-PHSRN (MDP 
IB), where glycine serves as a linker, and the C-terminal serine in the tripeptide increases 
specificity of this motif [75]. These peptides were designed and synthesized by He Dong in 
our laboratory. We intended to identify the best candidate for cell survival among 
sequences with and without cell adhesion motifs. Cell culture studies showed comparable 
results for PHSRN + RGD versus RGD alone; therefore we decided to continue with peptides 
carrying RGD only. Although the cell compatibility studies with this series of peptides were 
promising, the mechanical strength of the hydrogels was insufficient. Another student in 
our laboratory, Lorenzo Aulisa, modified the sequences in an attempt to improve the 
mechanical properties. The exchange of glutamine (Q) for serine (S) in the central block 
motif resulted in the two peptides E2(SL)6E2 and K2(SL)6K2. Whereas the negatively charged 
glutamic acid (E) in the flanking region allows for crosslinking with positively charged ions, 
such as Ca2+ or Mg2+; the antagonistic peptide with positively charged lysine (K) in the 
flanking region can utilize negatively charged ions, such as phosphate, to induce gelation. 
The increased number of amino acids in the flanking region provided improved water 
solubility. An additional advantage of this peptide architecture was the fact that the 
resulting hydrogels possess shear-thinning behavior and undergo quick shear-recovery. 
The peptide K2(SL)6K2 was modified further to create four different variants with 
MMP-2 specific cleavage motifs and either one or two lysine residues in the flanking region. 
In general, specificity of enzymatic cleavage by endopeptidases arises from the amino acid 
sequence. Occurrence of specific residues 5 positions N-terminal and 3 positions C-terminal 
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from the scissile bond (P5 - P3') has been demonstrated to affect recognition and increase 
the specificity of an enzyme for its substrate [74]. Two hexapeptides were designed, in 
which the consensus MMP-motif LRS (leucine-arginine-serine) C-terminally of the actual 
cleavage site was modified to LRG (leucine-arginine-glycine). Whereas glycine, similarly to 
serine, can be observed frequently in position P3' in MMP-2 susceptible substrates, this 
amino acid appeared more favorable as to maintain the pattern of alternating polar and 
nonpolar residues in the central block motif. The three amino acid residues N-terminally of 
the scissile bond were chosen based on cleavage site motifs described previously [74]. The 
sequences SLS-LRG (MDP 3B, 3D) and VLS-LRG (MDP 3C) were incorporated into the central 
block of K2(SL)6K2 (MDP 3), where addition of valine (V) 3 positions N-terminally of the 
scissile bond was expected to increase the specificity of the site. In order to compensate for 
the unfavorable influence of the hydrophobic residue in this position on self-assembly and 
gel formation, the peptide was elongated and this motif was flanked by an additional SL-
repeat on either side. Furthermore, a version of E2(SL)6E2 (MDP 2) with the cleavage motif 
SLS-LRG was synthesized (MDP 2B). 
After assessment of solubility, gelation properties and confirmation of enzymatic 
cleavage of these peptides, the sequence KSLSLSLRGSLSLSLK (MDP 3D) was chosen for 
further analysis. The expected fragments after enzymatic cleavage (3D-1, 3D-2) were 
synthesized to exclude that these could still assemble and form 3-sheet structures. For cell 
culture studies, this peptide was synthesized with the cell adhesion motif RGD, and 
compared to K2(SL)6K2 both with and without RGD. 
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3. Materials and Methods 
3.1. Peptide Synthesis 
All peptides, including the expected cleavage fragments were synthesized by solid phase 
chemistry on an Advanced Chemtech Apex 396 peptide synthesizer using a modified 
protocol specifically for MDPs as described previously [71]. After acylation of the N-termini 
and cleavage from the resin, the crude peptides were dissolved in de-ionized water at 5 
mg/mL and purified by dialysis in semipermeable membranes with a molecular weight cut-
off of 100-500 Da (Spectra/Por, Spectrum Laboratories Inc., Rancho Dominguez, CA). The 
water was changed every 12 hours for 5 days, the peptides were lyophilized and the 
resulting products were used for further analysis and cell culture experiments. The correct 
masses of all peptides were confirmed by matrix-assisted laser desorption/ionization time-
of-flight (MALDI-TOF) mass spectrometry. 
3.2. Gel Formation and Rheological Properties 
The lyophilized peptides were dissolved in de-ionized water containing 298 mM sucrose at 
20 mg/mL, and the pH was adjusted to 7.4. For E-series peptides, gelation was induced by 
addition of Mg2+ or Ca2+ ions (ratio of peptide molecules to ions of 1:4). For K-series 
peptides, phosphate buffered saline (1 x PBS, phosphate concentration of lOmM) was 
added, where lysine-containing peptides are cross-linked due to the presence of negatively 
charged phosphate ions. The final peptide concentration amounted to 10 mg/mL (1 % by 
weight). 
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To evaluate viscoelasticity and gelation behavior of MDP hydrogels, and in how far 
incorporation of bioactive motifs would affect these properties, oscillatory stress sweep 
analysis was performed 24 hours after induction of gelation on an AR-G2 rheometer (TA 
Instruments, NE). Fifty u l of gel were pipetted onto the center of the bottom plate, and the 
upper plate (parallel plate, 8 mm) was lowered to the default gap of 250 pirn. Storage 
moduli (C) and loss moduli (G") were measured as a function of oscillatory stress ranging 
from 0.01 to 1000 Pa at an angular frequency 0.5 rad/s and 10 points/decade. 
In order to evaluate shear recovery of the hydrogels, time sweep analysis was 
performed. This experiment contains three phases. During the first phase, a constant and 
low oscillatory stress is applied, followed by application of a very high load 5 min into the 
experiment. It finishes with a third phase, where the oscillatory stress goes back to the 
original level. The material undergoes shear recovery if its storage modulus returns to the 
original value within seconds. 
3.3. Cell Viability 
To assess the compatibility of the different peptide hydrogels with cell cultures, MTT assays 
for cell viability were conducted. For experiments with E(QL)6E, a previously developed 
immortalized cell line from human pulp-derived cells was utilized [76]. The cells were 
cultured in aMEM supplemented with 15% fetal bovine serum (FBS), 50 u.g/mL L-ascorbic 
acid 2-phosphate, 100 U/mL penicillin and 100 u.g/ml_ streptomycin, and incubated at 37°C 
with 5% C02. Subconfluent cells were detached using trypsin-EDTA (Invitrogen, Carlsbad, 
CA), and 1 x 105 cells were encapsulated per gel. Gelation was induced by adding Mg2+ to 
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the cell suspension. Gels containing cells were seeded in 96-well plates with a gel volume of 
100 u l , and 200 u± of medium were added on top of each gel 30 min later. Culture medium 
was changed every other day, and MTT assay for cell viability was performed on triplicate 
samples at different time points of the incubation period. Briefly, gels were incubated with 
200 u l of medium without serum containing 2 mg/mL of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) (Sigma-Aldrich, St. Louis, MO) for 3 hours. The solution 
was removed, and gel and cells were lysed in 200 u± DMSO (Sigma-Aldrich, St. Louis, MO), 
the plates were shaken thoroughly on a shaker for 5 min. Absorbance was measured in a 
96-well plate reader at 570 nm against a blank reading prepared from gels without cells. 
3.4. Cell Proliferation 
Actual cell numbers in hydrogels were determined by fluorometric quantification of DNA 
content using CyQuant cell proliferation assay kit (Invitrogen, Molecular Probes, Carlsbad, 
CA). For these proliferation studies, SHED from exfoliated deciduous teeth were used. Cells 
were cultured under conditions as listed above. Subconfluent cells of passage 5 were 
detached using trypsin EDTA (Invitrogen, Carlsbad, CA) for encapsulation. Several E- and K-
series peptides were included in these proliferation studies, as well as two commercially 
available hydrogels for three-dimensional cell culture: collagen type I (Rat Tail Collagen, 
Invitrogen, Carlsbad, CA) and PuraMatrix™, a peptide-based hydrogel system (BD 
Biosciences, San Jose, CA). 
Hydrogels were prepared as follows: A peptide stock solution was made in de-
ionized water containing 298 mM sucrose at 2 % by weight (20mg/mL). This solution was 
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mixed with an equal volume of cell suspension with a final peptide concentration of 1 % by 
weight, a cell number of 1 x 105 and a volume of 100 u l per gel. For E-series peptides, the 
cells were suspended in de-ionized water with 298 mM sucrose to maintain the appropriate 
osmolarity for cell culture, and with Ca2+ to induce gelation. For K-series peptides, the cells 
were suspended in 1 x PBS. All hydrogels with serine in the central block motif show shear-
thinning behavior. Therefore, the total volume of hydrogel needed for a particular 
experiment was prepared and 100 u l of gel were pipetted into a well of a 96-well plate for 
each sample. For each assay to be performed and for each time point and culture condition, 
3 or 5 samples were seeded. After 30 min, 200 u.1 of media were added to each well, and 
subsequently changed every 48 hrs. After 3, 7, and 14 days, samples were diluted in 1 mL 
PBS and pipetted up and down to disrupt the hydrogel. After centrifugation (3 min at 1000 
rpm), the supernatant was removed and cell pellets were frozen down at -80°C for further 
analysis. After completion of sample collection, these were thawed, and assays and 
measurements were performed on all samples at the same time. The number of cells in all 
samples was determined by fluorometric quantification of DNA content using CyQuant cell 
proliferation assay kit (Invitrogen, Carlsbad, CA) and a FLUOstar Optima fluorescence plate 
reader (BMG Laboratories, Durham, NC). Actual cell numbers were calculated based on a 
standard curve created from suspensions of known cell densities. Several proliferation 
studies were performed, and data were collected from at least 10 samples resulting from 
two independent experiments. One way analysis of variance (ANOVA) followed by Tukey 
test was performed to determine differences in cell numbers between different hydrogel 
systems using Kaleidagraph 4.03 software. The significance level was set to a = 0.5. 
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3.5. Hydrogel Degradation and Weight Loss 
Gels were prepared from the three peptides containing an enzyme cleavable site: 
K2(SL)3RG(SL)3K2 (MDP 3B), K(SL)3VLSLRG(SL)3K (MDP 3C) and K(SL)3RG(SL)3K (MDP3D). Their 
viscoelastic properties were assessed by oscillatory stress sweep rheometry. Whereas MDP 
3B formed mechanically stable hydrogels around pH 9, its storage modulus at pH 7.4 was 
lowest among the 3 cleavage peptides (G' = 42.7 Pa). Since this value did not meet our 
requirement for sufficient gel strength, MDP 3B was excluded from further experiments. 
The degradation profile of the remaining MDP 3C and D was determined, and K2(SL)6K2 
(MDP 3) was used as a control. For each sample, 50 u l of gel were transferred to a 
centrifuge tube after weighing the empty tube. After 30 min of equilibration, 200 u l PBS 
was added on top of each gel, and samples were stored at 37°C for 2 hrs. The PBS solution 
was then removed, and the weight of each gel was determined on an analytical balance as 
the difference between the weight of the empty tube and the tube containing the gel. 
Samples were 200 u± of 1) collagenase IV (Sigma-Aldrich, St. Louis, MO) at 3mg/mL in PBS, 
or 2) PBS as a negative control. Samples were run in triplicates, solutions were changed and 
the sample weight was determined every 24 hrs for 14 days. 
3.6. MMP-2-Specific Cleavage 
To assess MMP-2 specific cleavage, gels of the cleavage-peptides MDP 3C and D and of MDP 
3 as a control were prepared at a concentration of 20 mg/mL, and then mixed with MMP-2 
(Sigma-Aldrich, St. Louis, MO) in PBS, with the final concentrations being 10 mg/mL peptide 
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and 100 ng MMP-2 in a total volume of 100 u l . Samples were incubated at 37°C for 48 hrs, 
and enzymatic cleavage was assessed by mass spectrometry. 
Disintegration of the nanofibrous network formed from MDP 3D was furthermore 
visualized by vitreous ice cryo-transmission electron microscopy (cryoTEM) at pH 7.4 and a 
peptide concentration of 1 % by weight. A small quantity of the sample solution (2-3 u±) 
was applied to a TEM copper grid with holey carbon film purchased from Quantifoil (400 
mesh Cu grid, 1.2 urn hole diameter), and blotted with filter paper using a Vitroblot type FP 
5350/60 under 100% relative humidity for two seconds to create a thin layer of sample on 
the surface of the grid. The grid was plunged into liquid ethane and quickly transferred to 
liquid nitrogen. Samples were analyzed using JEOL 2010 TEM at an accelerating voltage of 
200 kV under low-dose imaging conditions. cryoTEM analysis of the samples was done by 
Lorenzo Aulisa. 
3.7. Circular Dichroism Spectroscopy 
Secondary structures were analyzed by measuring ellipticity spectra from 250 to 190 nm on 
a CD spectrometer. The full length peptide MDP 3D as well as the fragments MDP 3D-1 and 
MDP 3D-2 were dissolved in de-ionized water at 1% by weight, sonicated for 30 sec, the pH 
was adjusted to 7.4 and the solutions were left overnight. The peptides were then diluted to 
0.25 % by weight with de-ionized water and pipetted into a cuvette with 1mm path length 
for acquiring spectra. A blank reference of water was subtracted from the raw data before 
molar ellipticity was calculated. The calculation was based on the equation [8] = 
(8*MW)/(c*10*l*n), where [9] = molar ellipticity at X in mdeg, MW = molecular weight of 
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the peptide, c = concentration of the peptide in g/L, I = path length in cm, and n = number 
of amino acids in the peptide. 
3.8. Cell Migration and Spreading 
To determine whether the presence of the enzyme-cleavable site would encourage cell 
migration into the hydrogels, SHED were incubated with membrane-permeant fluorescein 
diacetate (Cell Tracker Green CMFDA, Invitrogen, Carlsbad CA) for 30 minutes, then washed 
with PBS, detached and seeded on top of hydrogels MDP 3A and 3E at a density of 5 x 104. 
Samples were fixed in 2 % paraformaldehyde and embedded for cryosectioning after 1 and 
5 days in culture. Sections of 10 urn thickness were prepared on a cryostat microtome, 
mounted on slides and stored at -20°C. Before use, cells were permeabilized with 5 % triton 
X in PBS, and cell nuclei were stained with DAPI (4',6-diamidino-2-phenylindole). Cells and 
hydrogels were visualized using a Zeiss LSM 510 Meta confocal microscope with an attached 
PMT. 
4. Results and Discussion 
4.1. Cell Viability 
The cell viability studies for the first E-series peptides (MDP 1, 1A and IB) revealed an 
increase of metabolic activity over a culture period of 14 days. Viability was lowest in 
hydrogels without RGD. The presence of both RGD and PHSRN did not result in better cell 
viability compared to peptides with RGD alone, and PHSRN was excluded from further 
studies. 
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Figure 7: Cell viability in E-
series peptides. Whereas 
addition of the cell 
adhesion motif RGD 
increased viability, the 
combination of both RGD 
with its synergistic site 
PHSRN did not result in 
further improvement of cell 
compatibility. 
4.2. Rheological Properties 
Oscillatory stress sweep and time sweep experiments were conducted to evaluate the 
viscoelastic properties of the described hydrogels. Storage (C) and loss modulus (G") are 
obtained, where G' is a measure of the deformation energy stored in the sample, and the 
loss modulus (G") a measure of the energy which is lost during the process and dissipated as 
heat. Results from oscillatory stress sweep analysis for E- and K-series hydrogels are 
visualized in Figure 8; additionally, a summary of all measurements is provided in Appendix 
E. For a comparison, data obtained from commercially available collagen type I at a 
concentration of 3mg/mL was plotted. Whereas gels from E(QL)6E are mechanically weak, 
exchange of glutamine for serine increased gel strength considerably. Addition of the cell 
adhesion motif RGD and the MMP-2 cleavage site resulted in a decrease of mechanical 
strength, but it remains well above our defined threshold for G' of 100 Pa, and is 













Besides increased gel strength, hydrogels 
prepared from peptides with serine in the 
central block revealed another useful 
characteristic. They were found to undergo 
shear-recovery and possess shear-thinning 
behavior, where the viscosity decreases with 
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 increasing load. This was first detected by 
Figure 8: Viscoelastic properties of 
MDP hydrogels. Storage (G') and loss handling and pipetting the gels, and later 
moduli (G") for hydrogels prepared from 
different peptide sequences. confirmed by oscillatory time sweep analysis. 
Figure 9 depicts shear recovery for MDP 2A, 3A and 3E. After application of a high load, the 
gels almost immediately return to the storage moduli observed during the first phase. This 
behavior makes MDPs an excellent injectable material and ideal for application into small 






Figure 9: Shear recovery of MDP 
hydrogels. A time sweep experiment 
shows shear-recovery properties of 
MDP 2A, 3A and 3E. After application of 
a high load 5 min into the experiment, 
the hydrogel returns to the original 
storage modulus (G'j within seconds. 
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4.3. Cell Proliferation 
Figure 10 summarizes proliferation data from several independent experiments. The graph 
shows cell numbers in two commercially available systems, collagen type I and 
PuraMatrix™, compared to different MDPs. 
For both the E- and K-series peptides, addition of RGD increased proliferation rates 
significantly (p < 0.05 at D7 and 14). Whereas E-series with and without RGD seemed to be 
more conducive for cell proliferation than K-series, addition of the enzyme-cleavable site to 
K-series peptides resulted in higher proliferation rates, which were comparable to both 
commercially available systems as well as E-series. The difference between 
K(SL)3RG(SL)3KGRGDS and either collagen I or PuraMatrix was statistically not significant. 
MDPs offer the possibility of modification and design of customized scaffolds, which does 
not exist for the commercially available systems. 
A summary of the statistical analysis of differences between the hydrogel systems at 
the different time points of the incubation period can be found in Appendix D. 
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Figure 10: Comparison of cell proliferation in different hydrogels. Cell numbers were 
determined after 3, 7 and 14 days in culture. Columns represent means, error bars depict 
standard deviations (n = 10). 
4.4. Hydrogel Degradation and MMP-2 - Specific Cleavage 
Figure 11 shows weight loss of the cleavage peptides K(SL)3VLSLRG(SL)3K (MDP 3C) and 
K(SL)3RG(SL)3K (MDP 3D) as well as from K2(SL)6K2 (MDP 3) when incubated with either 
collagenase IV or PBS (control). For all gels, incubation with PBS resulted in a weight loss of 
5 - 10% over a 2-week period, where a small amount of peptide was washed off due to 
daily changes of the supernatant. Incubation with collagenase IV resulted in complete 
digestion of both cleavage peptides after 14 days, whereas the control peptide hydrogels 
were reduced by only 25 % of their original weight. 
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Figure 11: Weight loss after enzymatic degradation. Hydrogels from MDP 3C and 3D with 
cleavage sites as well as from MDP 3 (control) were incubated with collagenase IV or PBS. 
The weight of each hydrogel was determined every day. Data points show averages of three 
samples (n = 3). Weight loss is depicted as a percentage where the weight at the beginning 
of the experiment was set to 100 %. Whereas MDP3 without a cleavage site is reduced by 25 
% of its original weight with collagenase IV, both cleavage peptides are degraded completely 
within 14 days. Control samples in PBS show little weight loss. 
To test specific degradation, MMP-2 was used for the following experiments. Upon 
mixture of a 2 % by weight hydrogel of MDP 3C, 3D or MDP 3 (control) with MMP-2 in PBS 
at a ratio of 1:1, the hydrogels reform, but cleavage peptides are degraded after 48 hrs of 
incubation at 37°C. After MALDI-TOF mass spectrometry, the control K2(SL)6K2 showed the 
expected peak before as well as after incubation with MMP-2. The results for both cleavage 
peptides were nearly identical. One peak according to the mass of the peptide molecule 
could be observed before incubation, but several fragments afterwards. The peak with the 
highest intensity was identified as the smaller fragment KSLSLS, a small peak represented 
the larger fragment, LRGSLSLSLK. Several additional peaks were present, part of which 
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corresponded to smaller peptide fragments present in the mix. This might be attributed to 
the fact that after cleavage into the two main fragments, the smaller peptide molecules are 
more susceptible to further degradation. Some of the peaks could not be identified as 
cleavage fragments, which might be due to the enzyme digesting itself. Figure 12 shows the 
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Figure 12: Mass spectrometry before and after enzymatic degradation. The control peptide 
MDP 3 shows a single peak before and after digestion, the cleavage peptide is degraded and 
multiple fragments can be observed. The expected fragments after cleavage KSLSLS and 
LRGSLSLSLK are both present. Some of the fragments could be identified as cleavage 
products, whereas some of the peaks remained unidentified. 
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To characterize the profile of enzymatic digestion, two different procedures were 
chosen. Addition of collagenase IV on top of the hydrogels resulted in a degradation profile 
showing continuous mass loss, indicating surface erosion of the material. For bulk 
degradation, an initial plateau phase would be expected, followed by a rapid drop of the 
curve. In this case, the enzyme would diffuse into the gel and start breaking up peptide 
molecules internally, but the initial mass of the material would be maintained for some time 
after the start of exposure, until it collapses rapidly at a critical point of weakened internal 
architecture. Surface degradation is the preferred mechanism for biological applications, as 
it will allow migrating cells to locally degrade the matrix as they move along while overall 
mechanical integrity of the scaffold is maintained until sufficient amounts of ECM have been 
produced to replace the synthetic material. Mixture of hydrogels with MMP-2 resulted in 
more rapid disruption of the fibrous network, as can be expected due to the largely 
increased surface area for the enzyme to attack, and higher specificity of MMP-2. The 
preparation of collagenase IV contains a varying mixture of enzymes and digests a wider 
range of substrates. The first results after incubation with collagenase IV therefore show 
that the designed peptide with cleavage site is susceptible to enzymatic degradation. 
Digestion with MMP-2 confirms specificity of this enzyme towards the substrate we 
created. The fast degradation of the hydrogel with MMP-2 compared to collagenase IV 
might be explained by the difference in preparation (mixing the solutions rather than 
adding the enzyme on top), and the higher specificity of MMP-2 for the substrate. 
This series of experiments confirmed that specific digestion of MDPs occurs when 
required amino acid residues are present in certain positions relative to the scissile bond: a 
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hydrophobic amino acid at P I ' followed by a basic amino acid and a small residue. Although 
specificity of the region N-terminally of the cleavage site has been shown to arise from 
proline, valine or isoleucine preferred in P3 [74], we did not observe more efficient cleavage 
for MDP 3C. Due to the almost identical profile of degradation for MDP 3D and C from the 
weight loss experiment and from mass spectrometry, we concluded that the additional 
valine in the sequence did not increase the specificity or accelerate the degradation 
process. Therefore, MDP 3D, which is preferable due to its shorter sequence, better water 
solubility and higher storage modulus, was chosen for further analysis. 
Degradation of MDP 3D nanofibers was visualized by cryoTEM as depicted in Figure 
13. The dense fibrous network changed after 48 hrs of incubation with MMP-2 and 
transformed into amorphous aggregates, indicating cleavage and subsequent disintegration 
of the hydrogel. CryoTEM images were taken by Lorenzo Aulisa. 
Figure 13: CryoTEM before and after enzymatic degradation. Images were taken before 
and 48 hrs after incubation with MMP-2. MDP 3D forms a dense fibrous network, after 
cleavage the nanofibers disintegrate and amorphous aggregates remain. Macroscopically, 
the gel turns into liquid. 
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Both peptide sequences synthesized analog to the expected C- and N-terminal 
cleavage fragments did not form gels and remained as liquid solutions capable of flowing. 
To exclude that the fragments could still adopt 3-sheet conformation, circular dichroism 
spectroscopy was performed on both fragments MDP 3D-1 and 3D-2 and the full length 
MDP 3D. Profiling the secondary structures of these peptides by CD and examining the 
presence of 6-sheets can provide basic information on their assembling capability. The CD 
spectra of 3-sheets are characterized by a minimum at 216 nm and a maximum at 195 nm, 
while these of random coils show a maximum at 218 nm and a minimum at 198 nm [77]. 
The profiles for MDP 3D and its fragments can be seen in Figure 14. Whereas the full length 
peptide clearly showed 3-sheet conformation with the described maximum and minimum, 
both fragments displayed the profile of random coils. This data suggests that the truncated 
peptides after degradation of the starting material will no longer be able to assemble and 
form insoluble aggregates, which is a critical point for any in vivo applications. 
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Figure 14: Circular dichroism 
spectra. The full length MDP 3D 
(blue) adopts 6-sheet 
conformation, the shorter N-
terminal fragment (red) and the 
C-terminal fragment (green) 
remain as random coils. 
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4.5. Cell Spreading and Migration 
To assess cellular morphology in different hydrogel systems, green-fluorescent SHED were 
seeded into collagen, PuraMatrix™, and E-and K-series of MDPs. Figure 15 shows the cells in 
these different matrices. The natural collagen matrix proved highly conducive for cell 
spreading, resulting in a spindle-shaped morphology (15 A). Cells in peptide hydrogels 
without cell adhesion motif appeared round and balled up (15 B, C, E). When RGD was 
present, the cell bodies were more spread out (15 D, F). Presence of the cleavage site 
seemed to enhance spreading (15 G). However, presence of both the enzyme-cleavable site 
and the cell adhesion motif RGD resulted in a synergistic effect, with visibly different cell 
morphology and spread-out cell bodies (15 H). This is in accordance with previous work, 
which demonstrated that initial cell spreading is dependent on proteolytic susceptibility of 
the matrix [78]. 
Furthermore, we hypothesized that the possibility of cell-mediated degradation 
would enable migration and result in penetration of the cells into the hydrogels. Therefore, 
we seeded green-fluorescent SHED on top of MDP 3A and 3E (Figure 16). After 1 day in 
culture, the cells could be seen covering the top as a monolayer in both cases (16 A, C). 4 
days later, MDP 3A still looked similar (16 B), whereas cells on MDP 3E had started to 
migrate into the matrix (16 D), indicating that if the cells were able to degrade the matrix 
around them, cell movement was facilitated. 
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Figure 15: Confocal Microscopy of cells in different hydrogels. Images A - H show green-
fluorescent SHED cells encapsulated in Collagen I (A), PuraMatrix™ (B), E2(SL)6E2 (C), 
E2(SL)6E2GRGDS (D), K2(SL)6K2 (E), K2(SL)6K2GRGDS (F), K(SL)3RG(SL)3K (G) and 
K(SL)3RG(SL)3KGRGDS (H). 
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Figure 16: Cell migration into hydrogels. Green-fluorescent cells were seeded on top ofMDP 
3A without cleavage site (A, B) and MDP 3E where the cleavage motif is present (C, D). Both 
peptides carry the cell adhesion motif RGD. Images show cells after 1 day (A, C) and after 5 
days (B, D) in culture. Whereas cells remain as a monolayer on top of MDP 3A (B), they 
migrate and spread into MDP 3E (D) The red arrows indicate the top of the gel. 
In conclusion, incorporation of an MMP-2 specific cleavage motif in (3-sheet forming 
peptides resulted in enzyme-mediated digestion and collapse of the hydrogel due to 
disruption of the nanofibrous network. Although similar effects have been demonstrated 
for other hydrogel systems including gels prepared from modified PEG [79 - 81] or self-
assembling peptide amphiphiles [82], only one report has shown proteolytic susceptibility 
of P-sheet-forming peptides [83]. In this case, incorporation of the cleavage motif required 
elongation of the starting peptide of 16 amino acid residues to a length of 30 to ensure (3-
sheet formation and gelation. 
Furthermore, we demonstrate an immediate effect of the peptide design on cellular 
behavior, where incorporation of the cleavage site markedly enhanced cell viability, 
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spreading and migration. This specific interaction of cells with the synthetic matrix 
surrounding them is another step towards the development of ECM-mimics. The versatility 
of MDPs leaves a variety of possibilities for further modifications and the design of custom-
made scaffolds for regenerative medicine. 
5. Troubleshooting 
5.1. Cell Compatibility and Purification 
After resolving the problem of mechanically weak hydrogels by changing from QL to SL-
series peptides, an issue arose as the cell viability in the new gels was comparably low, 
which was confirmed by repeated measurements. Since E-series peptides are difficult to 
purify by HPLC due to the charge effect, which results in binding of the molecules to the 
column and a low yield, alternative purification methods were explored. A comparison using 
K-peptides revealed that purification by HPLC resolved the toxicity issues. In order to 
circumvent loss of material in E-peptides, we tried dialysis for purification. Whereas this 
method resulted in markedly increased cell viability, another advantage of this procedure 
was that after dissolving the purified peptide powder in water, the pH was already at 7.0, 
and further adjustment was usually not necessary. 
5.2. Gelation Conditions 
The protocol for gelation and cell encapsulation was changed after switching from QL- to SL-
series. For QL-series, the peptide stock solution as liquid, it was pipetted into the wells of a 
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96-well plate, and individually mixed with an equal volume of cell suspension containing the 
ions to induce gelation. Gels formed within 3-5 minutes. 
For SL-series, the peptide stock solution already forms a gel. Pipetting the peptide 
stock, mixing it with the cell suspension and keeping all volumes constant was therefore 
challenging. The procedure was changed such that instead of mixing gels individually in the 
96-well plates, the required volume of gel containing the cells was prepared in a centrifuge 
tube, and transferred to the wells in 100 uL aliquots. Switching to a 1000 uL - pipette 
instead of a 200uL - pipette made it easier to handle the gels due to the larger opening at 
the tip. 
5.3. Cell Proliferation Assays 
Whereas the CyQuant cell proliferation assay worked well with E-series peptides, problems 
occurred when it was used with the K-series, and the results were implausible. This might 
be due to interference of positive charges on these peptides with the DNA-binding dye used 
for this assay. A WST - Quick cell proliferation assay kit (BioVision, Mountain View, CA) was 
tried as an alternative, and a series of experiments was conducted with collagen gels, which 
worked well. However, in K-series hydrogels, the WST dye, which indicates cell metabolic 
activity was not properly released from the gels, and the absorbance readings were likely to 
be too low. Other procedures we tried included cell counts using a hemacytometer and 
trypan blue stain, or a coulter counter. However, the trypan blue stained the gels as well, 
and the cells and gel remnants formed lumps, which made it impossible to obtain accurate 
cell counts. Therefore, we returned to the MTT assay we had worked with initially. This 
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turned out to work with K-series peptides, as after the incubation period, the gels and cells 
lysed in dimethyl sulfoxide, an organic solvent which dissolves the peptides. Measurements 
were now possible. 
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CHAPTER V: SPECIFIC AIM 2 
To assess the potential of this system for cell differentiation after application of growth 
and differentiation factors. In a second step, bioactive molecules are incorporated into 
peptide hydrogels, which will aid in cell differentiation and tissue formation. 
1. Summary 
Dental stem cells have been shown to possess plasticity [25, 27], and osteogenic 
supplements in the cell culture media promote cell differentiation towards an odontoblast-
like phenotype [60 - 62]. In our earlier work on peptide amphiphiles, we demonstrated that 
both SHED and DPSC differentiate in the hydrogel matrix after addition of inorganic 
phosphate and dexamethasone. After 4 weeks in culture, the cells express osteoblast- and 
odontoblast- marker genes, increase their alkaline phosphatase activity, form collagen and 
initiate mineral formation. To confirm that multidomain peptides are equally conducive for 
dental stem cell proliferation and differentiation, a similar set of experiments was 
conducted where cells were grown in MDP 1A. The results were comparable to those from 
our pilot study, indicating that multidomain peptide hydrogels are a suitable scaffold for 
these cells. 
In a next step, we evaluated the effect of dexamethasone and 3-glycerophosphate 
alone and in combination in monolayer cell cultures to get a better idea of their role in 
promoting cell differentiation. Whereas both compounds decreased cell proliferation and 
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increased alkaline phosphatase activity, it remained questionable whether a synergistic 
effect existed for the combination of both. 
In order to customize our system for future in vivo applications, we attempted to 
incorporate these differentiation factors into the hydrogel matrix. Dexamethasone was 
covalently linked to the peptide molecule via a succinyl linker. However, when used in cell 
culture studies, no effect on cellular behavior could be observed. This might be due to the 
fact that dexamethasone, a small and hydrophobic molecule, does not act via cell 
membrane receptors, but induces intracellular changes after passing the plasma 
membrane. Covalent linkage of dexamethasone to the peptide might prevent the molecule 
from reaching its intracellular target. Alternative ways to incorporate dexamethasone into 
multidomain peptides are currently investigated in the Hartgerink laboratory. The 
incorporation of 3-glycerophosphate was successful, as the molecule can be used to induce 
gelation in positively charged multidomain peptides, resulting in comparable gel strength to 
previously used PBS. At the same time, ^-glycerophosphate can act as a bioactive factor. 
Another mechanism we explored for growth factor incorporation was via heparin-
binding. Heparin, a negatively charged glycosaminoglycan, is present in natural extracellular 
matrix, where it can bind growth factors, protect them from proteolytic degradation and 
prolong their activity. This effect can be mimicked by incorporating heparin into synthetic 
matrices. Heparin was utilized for gelation of K-series peptides and was successfully 
integrated into the gels, at the same time increasing gel strength. Heparin was exploited to 
bind vascular endothelial growth factor (VEGF), a potent differentiation factor for the 
induction of new blood vessel formation, which is a critical process for any tissue 
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engineering approach. Prolonged release of VEGF from heparin-containing gels compared 
to controls could be demonstrated. 
The work summarized in Specific Aim 1 led to the development of a peptide 
sequence which features the cell adhesion motif RGD and an MMP-2 specific enzyme-
cleavable site. As established in Specific Aim 2, this peptide is furthermore capable of 
binding 3-glycerophosphate and heparin. With these building blocks, we constructed a 
customized scaffold for dental stem cell delivery. In vitro cell culture with SHED and DPSC 
followed by histologic analysis demonstrated that the cells deposit collagen and mineral, 
both indicators for cellular differentiation. This work laid the basis for the in vivo 
experiments described in Specific Aim 3. 
2. Proliferation and Differentiation in Multidomain Peptides 
To confirm that multidomain peptides allow for cell proliferation and differentiation 
comparable to peptide amphiphiles, a similar set of experiments was performed to what 
had been done before [84]. SHED and DPSC cells were encapsulated in multidomain peptide 
hydrogels and cultured for four weeks after addition of osteogenic supplements of inorganic 
phosphate and dexamethasone. Samples were taken at different time points to determine 
cell numbers and alkaline phosphatase activity. After 28 days, RNA was extracted from the 
cells in gels, and quantitative real-time PCR was performed to analyze the expression profile 
of marker genes of matrix deposition and mineralization in treated and control cells. 
65 
3. Materials and Methods 
3.1. Cell Culture 
SHED and DPSC were cultured in aMEM supplemented with 10% fetal bovine serum, 50 
u.g/mL L-ascorbic acid 2-phosphate, 100 U/mL penicillin and 100 u.g/mL streptomycin, and 
incubated at 37°C with 5% C02. Subconfluent cells of passage 4 were detached using 
trypsin-EDTA (Invitrogen, Carlsbad, CA), resuspended in PBS, and cells were encapsulated in 
MDP 1A hydrogels at a density of 1 x 105 cells per gel as described in Chapter IV: 3.3. Both 
control and treated groups received aMEM with an increased serum concentration of 20% 
FBS, and the other supplements as listed above. For treated groups, 10 mM B-
glycerophosphate and 10 nM dexamethasone were added. Culture medium was changed 
every other day for a culture period of 4 weeks. Samples for cell proliferation assays and 
alkaline phosphatase activity were seeded in triplicates. For Real-time PCR analysis, 6 gels 
per group were pooled to get sufficient amounts of RNA. 
3.2. DNA Content and Alkaline Phosphatase Activity 
After 3, 7,14, 21 and 28 days, cells were harvested by diluting the peptide hydrogels in 1 mL 
PBS and mechanical disruption of the gels by pipetting up and down. Cell pellets were 
collected after centrifugation (5 min at 1000 rpm), and frozen at -80°C. As soon as the 
collection of all samples was completed, these were thawed, and assays and measurements 
were performed on all samples at the same time. DNA content was determined by 
fluorometric quantification using CyQuant cell proliferation assay kit (Invitrogen, Molecular 
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Probes, Carlsbad, CA) and a FLUOstar Optima fluorescence plate reader (BMG Laboratories, 
Durham, NC). Actual cell numbers were calculated based on a standard curve created from 
suspensions of known cell densities. 
Samples for the detection of alkaline phosphatase (ALP) activity were prepared as 
described for the DNA assay. Cell pellets were resuspended in 60 u l PBS. After addition of 
60 u l alkaline buffer and 100 u± alkaline substrate solution (SIGMA-Aldrich, St. Louis, MO), 
samples were incubated at 37°C for 60 min and the liberated p-nitrophenol was measured 
spectrophotometrically at 410 nm. Samples were compared to a dilution series of p-
nitrophenol standard (SIGMA-Aldrich, St. Louis, MO) and ALP activity was normalized to the 
corresponding cell numbers obtained from the proliferation assay. 
3.3. Quantitative Real-time PCR 
To assess the effect of osteogenic induction on the expression of genes involved in 
differentiation, matrix formation and mineralization, real-time PCR was performed on 
samples after 28 days of culture. RNA was extracted using RNA Stat 60 (Tel-Test Inc., 
Friendswood, TX) from 6 gels per group, which were pooled to get sufficient amounts. 
Reverse transcription was performed according to standard protocols for cDNA synthesis 
using an oligo-dT primer. One u.g of RNA was used for one reaction of reverse transcription, 
which provided cDNA for 10 real-time PCR reactions. Primer sets for marker genes of 
osteoblast and odontoblast differentiation were designed using primer 3 software [85] from 
mRNA sequences published in GenBank as follows: collagen a(l)l (Col I) (NM_000088), 
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alkaline phosphatase (ALP) (NM_000478), bone sialoprotein (Bsp) (NM_000582), 
osteocalcin (Oc) (X_53698), Runx2 (NM_004348), dentin sialophosphoprotein (Dspp) 
(NM_014208), and glyceraldehyde 3 phosphate dehydrogenase (GAPDH) (M_33197) as an 
internal control. Primer efficiency was determined prior to quantification by running a 
dilution series of cDNA from differentiated cells for each primer pair. Conditions for real-
time PCR were as follows: After a denaturation step at 95°C for 15 minutes, 60 cycles were 
run with 95°C (15 sec), 60°C (30 sec), 72°C (30 sec), with a final dissociation step to generate 
the dissociation profile of the PCR products. Reactions were run in triplicates (ABI Prism 
7900HT), gene expression was quantified using SYBR green (QuantiTect SYBR green PCR kit, 
Qiagen Inc., Valencia, CA) and normalized to GAPDH activity in respective samples. 
Calculations of fold-change in gene expression between controls and treated samples were 
performed according to the Pfaffl-method for relative quantification in real-time PCR [86]. 
4. Results and Discussion 
4.1. Cell Proliferation 
The results from the cell proliferation assays are depicted in Figure 17. Both cell lines show 
an increase in cell numbers over the four-week culture period, where proliferation rates in 
SHED are markedly higher than in DPSC. This is in accordance with our previous work on 
peptide amphiphiles [84], and with the literature, where SHED and DPSC proliferation rates 
were compared in monolayer cultures [27]. Proliferation is slightly reduced when 
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osteogenic supplements are added, which is to be expected due to the inverse relationship 
between cell proliferation and differentiation. 
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Figure 17: Cell proliferation for SHED and DPSC in E(QL)6EGRGDS. SHED proliferate faster. A 
slight decrease in proliferation can be observed for cells treated with osteogenic 
supplements. Columns and bars show means and standard deviations (n = 3). 
4.2. Cell Differentiation 
To evaluate indicators of cellular differentiation, we first determined alkaline phosphatase 
(ALP) activity in treated and control cells. In mineralizing tissues, the enzyme ALP cleaves 
extracellular pyrophosphate, an inhibitor of hydroxyapatite crystal formation, to inorganic 
phosphate, which is needed for matrix calcification [87]. ALP is commonly quantified as an 
early differentiation marker and indicator of lineage commitment towards a mineralizing 
cell type. Figure 18 shows ALP levels in treated cells and controls at different time points of 
a four-week culture period. ALP activity was elevated in treated cells, and markedly higher 
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in DPSC compared to SHED, which is in accordance with our observations in peptide 
amphiphiles, reflecting a higher potential for mineralization in DPSC [84]. 
bGP + dexamethasone SHED ALP Activity 
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Figure 18: Alkaline phosphatase (ALP) levels in SHED and DPSC. Cells were cultured in 
regular media (control in grey) or treated with 6-glycerophosphate (bGP) in combination 
with dexamethasone (blue) (n = 3). ALP activity is increased in treated groups for both cell 
lines, and highest in DPSC, indicating their tendency towards mineralization. 
For real-time PCR analysis, the following markers of matrix deposition and 
mineralization were chosen: collagen I (Col I), bone sialoprotein (Bsp), osteocalcin (Oc), 
Runx2, and dentin sialophosphoprotein (Dspp). These genes are commonly used as markers 
of mineralization [88, 89, 27]. Col I is the major component of extracellular matrix in dentin 
[90]. The acidic proteins Bsp and Dspp share common expression in bone and teeth and 
induce mineral nucleation [91]. Runx2, a transcription factor, is known as the master 
regulator of osteoblast differentiation, exhibiting similar roles in dental development and 
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odontoblast cytodifferentiation [92]. Oc is considered a marker of differentiated osteoblasts 
[93], but can also be detected in pulp-derived cells [88]. 
Expression of all the genes we examined was increased in cells treated with 3-
glycerophosphate and dexamethasone. The difference in gene expression in treated cells 
and controls are depicted in Figure 19. The change compared to control groups was not 
dramatic (for example, for DPSC the fold-increase of marker gene expression ranged from 
1.3 to 5.1), which might be due to the fact that growth factors in the serum, which was 
added at a fairly high concentration of 20% to support three-dimensional growth, might 
induce differentiation in control groups to some extent. Although the results have to be 
looked at with caution, they indicate that cellular differentiation in peptide hydrogels is 
possible, which confirms results from earlier experiments in peptide amphiphiles (see 
Appendix B). In order to evaluate the differentiation potential of SHED and DPSC 
thoroughly, experiments should be conducted under serum-free or low-serum conditions. 
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Figure 19: Gene Expression in SHED and DPSC. Fold increase of marker genes of osteoblast 
and odontoblast lineages. Results are normalized to GAPDH levels in each sample. An 
increase can be observed for all genes after treatment with 6-glycerophosphate (bGP) with 
dexamethasone. Control groups were set to 1, which is indicated by the dashed line. 
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In summary, we were confident that multidomain peptides were conducive for cells 
proliferation and differentiation, similar to peptide amphiphiles. These data were 
important, as they led us to continue working with this peptide architecture and start 
modifications to improve the properties of multidomain peptides. The first concern to be 
addressed was the problem of mechanically instable hydrogels. Although cells were seeded 
for fixation and processing for histologic analysis for this set of experiments, the gels did not 
withstand the manipulation for processing and embedding, and this attempt remained 
unsuccessful. 
4.3. Studies with Oexamethasone and (^-glycerophosphate 
To evaluate the effect of dexamethasone and ^-glycerophosphate alone and in combination 
on cell cultures, a simple experiment was performed in which SHED proliferation and ALP 
activity were determined at different time points of a 2-week culture period. 
SHED were grown in monolayer cultures and treated with these supplements. Cells 
of passage 4 were seeded at a density of 2500 cells/well into 96 well-plates and cultured in 
aMEM with 5% FBS and antibiotics as described before. The reduced serum concentration 
should minimize the effect of growth factors contained in the serum. All samples were 
seeded in triplicates. After 3, 7, 10 and 14 days, a Quick cell proliferation assay (BioVision, 
Mountain View, CA) was performed to determine cell numbers. Alkaline phosphatase 
activity was quantified as described in 3.2. Figure 20 summarizes the results. All 
supplements slightly decreased cell proliferation rates and increased alkaline phosphatase 
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levels. However, based on our results it was not possible to identify a candidate supplement 
or combination with the highest potential to effect cell differentiation. Therefore, our goal 
was to incorporate both compounds into multidomain peptides. 
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Figure 20: Proliferation and ALP activity in monolayer SHED cells. Treatment with 
osteogenic supplements slightly decreased cell proliferation, whereas alkaline phosphatase 
levels were increased. 
4.4. Incorporation of Dexamethasone into Multidomain Peptides 
Dexamethasone, a synthetic glucocorticoid, has been used to induce osteogenic 
differentiation in osteoblasts [93 - 96], and it is known to stimulate differentiation of 
odontoblast-like cells in dental pulp cultures [61]. The experiments described in the 
previous sections demonstrate that dental pulp stem cells treated with dexamethasone and 
inorganic phosphate decrease their proliferation rates and increase alkaline phosphatase 
activity and expression of genes associated with matrix deposition and mineralization. 
Furthermore, dexamethasone not only promotes cellular differentiation, but exerts an anti-
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inflammatory effect. In dentistry, it is commonly administered to counteract inflammation 
and swelling after dental surgery. This could be useful for in vivo applications of peptide 
hydrogels, where inflammation will be present at the site of injury due to tissue damage 
either by traumatic impact or caused by bacterial toxins. 
Our goal was to incorporate dexamethasone into our 
multidomain peptides by covalently linking the molecule 
to the peptide chain. The entire work on dexamethasone 
coupling to the peptide K2(QL)6K2, purification and 
Figure 21: Chemical structure confirmation of covalent linkage was done by Erica Bakota 
of dexamethasone. 
in our laboratory. Dexamethasone was reacted with 
succinic anhydride to produce a 4-carbon linker molecule. The carboxylic acid group at the 
end of the linker allowed her to couple this molecule to the N-terminus of the peptide using 
standard peptide coupling chemistry, resulting in amide bond formation between the 
peptide and the succinate linker. The coupling of dexamethasone to succinic anhydride was 
monitored by thin layer chromatography (TLC), and the product was purified using silica 
chromatography. The final product was purified by high-performance liquid 
chromatography (HPLC), and the expected mass was determined by mass spectrometry to 
confirm successful coupling. 
Since dexamethasone is hydrophobic, it could be expected that attachment of this 
molecule to the peptide chain will affect the gelation properties dramatically. Indeed this 
was the case; K2(QL)6K2, which forms stable hydrogels at basic pH, does not form a gel when 
dexamethasone is covalently linked to the peptide. However, the concentration at which 
74 
dexamethasone is used as an osteogenic supplement is 10 nM. Two peptides of the same 
sequence with and without dexamethasone can thus be mixed to form a gel. In the case of 
K2(QL)6K2 with dexamethasone attached, the molecular weight of the molecule is 2410.75 
Da. Only 24.11 ng/mL are needed to prepare a 10 nM solution, as compared to 10 mg/mL 
peptide stock concentration (1 % by weight or 5 mM) without dex. This small amount is not 
expected to interfere with gelation or mechanical stability. 
However, the effect of dexamethasone on cellular behavior when bound to a 
peptide molecule was first evaluated in a monolayer experiment with analogous set-up as 
described in section 3, where dexamethasone was covalently linked to K2(QL)6K2. Peptide 
stock solution was added to cell culture media to obtain dexamethasone concentrations of 
10 nM, 100 nM and 1000 nM. Media containing supplements were changed every other 
day. The results are summarized in Figure 22. We could neither detect an influence on cell 
proliferation nor alkaline phosphatase activity after addition of peptide-bound 
dexamethasone. This might be explained by the fact that this compound, due to its small 
size and hydrophobicity, is able to pass the cell's lipid bilayer membrane and directly 
activate intracellular targets rather than acting via membrane-bound receptors. Covalent 
linkage of dexamethasone to the peptide might prevent the molecule from reaching its 
intracellular target. Whereas my work on dexamethasone was put on halt at this point, 
alternative ways to incorporate this compound into multidomain peptides are currently 
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Figure 22: Treatment with peptide-bound dexamethasone. Proliferation rates and alkaline 
phosphatase activity after treatment with peptide-bound dexamethasone seemed 
unaffected and similar to controls. 
4.5. Incorporation of ^-glycerophosphate into Multidomain Peptides 
Inorganic phosphate is commonly used as an osteogenic supplement. In mineralizing 
tissues, P043" is needed to build the crystal lattice in combination with calcium- and 
hydroxyl-ions to form hydroxyapatite, the predominant mineral in bone and teeth. The fact 
that gelation of multidomain peptides carrying positively charged lysine residues can be 
induced by addition of phosphate led to the idea that PBS could be exchanged with a 
solution of B-glycerophosphate. Therefore, mechanical strength of MDP 3 was tested after 
gelation with either PBS or 3-glycerophosphate. l x PBS has a phosphate concentration of 
lOmM, which in our system is reduced to 5mM as peptide stock solution is mixed with the 
cell suspension in PBS. In order to maintain osmolarity, B-glycerophosphate was dissolved in 
de-ionized water with sucrose and brought to a concentration of 10 mM. After mixture with 
the peptide stock solution, the final concentrations were as follows: 
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- Gel with PBS: 1 % by weight of peptide, 0.5 x PBS (5 mM phosphate), 149 mM sucrose 
- Gel with B-GP: 1 % by weight of peptide, 5 mM B-glycerophosphate, 298 mM sucrose. 
Stress sweep analysis was performed to compare differently prepared gels (Figure 23). Both 
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Figure 23: Mechanical strength of 
K2(SL)6K2 prepared with different 
solutions. When the peptide is 
prepared in water alone, the gel 
strength is lowest (black). Dissolving 
the peptide in water with sucrose 
increases gel strength (brown). 
Addition of PBS results in a further 
increase of mechanical stability 
(green). A similar effect can be 
observed with 6-glycerophosphate 
(red). If PBS and BGP are combined, 
get strength decreases slightly, 
1000 indicating that the optimum 
phosphate concentration is 
exceeded (blue). 
4.6. Incorporation of Heparin into Multidomain Peptides 
In order to provide proper nutrition for cells seeded in the scaffold and delivered to the site 
of injury, it is absolutely essential to provide sufficient blood supply. It has been shown that 
growth factors, such as vascular endothelial growth factor (VEGF) or fibroblast growth 
factor -2 (FGF2), can boost signaling for new blood vessel formation and induce sprouting of 
new capillary networks from existing microvessels [97 - 99]. A common strategy of 
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incorporation uses the ability of the glycosaminoglycan heparin to bind growth factors. 
Heparin is a biopolymer of variably sulfated repeating disaccharide units of iduronic acid 
and glucosamine, which is present in natural ECM. It has the highest negative charge 
density of any know biological molecule. Heparin has been found to not only bind growth 
factors, but to protect them from enzymatic degradation and prolong their bioactivity [100]. 
Slow and continuous release of growth factors bound to synthetic systems via heparin has 
been demonstrated over a time period of 10 days to up to 42 days [101, 102]. Thus we 
hypothesized that inclusion of small amounts of heparin would regulate growth factor 
release. 
Heparin can be bound to the hydrogels via specific peptide sequences. Consensus 
heparin-binding domains follow the pattern XBBBXXBX or XBBXBX, where X is a hydrophobic 
amino acid and B a basic amino acid [103]. Heparin-binding sequences have been utilized in 
peptide amphiphile systems [101, 104] or other hydrogels such as hyaluronan [102]. 
Stimulation of extensive new blood vessel formation after binding and slow release of 
angiogenic growth factors from peptide hydrogels via heparin-binding has been 
demonstrated recently in a rat corneal assay [101]. Since growth factor binding to these 
heparin-binding domains seemed most likely to be due to a charge effect, we hypothesized 
that it would be possible to incorporate heparin into K-series multidomain peptides without 
specific heparin-binding domains. 
A series of experiments with heparin (heparin sodium salt from porcine intestinal 
mucosa, SIGMA-Aldrich, St. Louis, MO) was performed. In order to identify optimum 
concentrations of both heparin and peptide, heparin concentrations between 1 and 10 
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mg/mL in water with 298 mM sucrose or in PBS were tested with peptide stock solutions 
with concentrations from 1 % to 3 % by weight. After preparation of the peptide stock, the 
heparin-containing solution was added and gently mixed with the peptide. Gels were left to 
equilibrate for 30 min, and proper gelation was evaluated. At too high heparin 
concentrations, a precipitate would form, which was evident after centrifugation of samples 
for 1 min at 14,000 rpm. An increase of peptide concentration would allow for the 
incorporation of higher concentrations of heparin. Oscillatory stress sweep analysis was 
performed after proper gelation to evaluate the mechanical properties. We were able to 
form stable hydrogels from K2(SL)6K2, K2(SL)3RG(SL)3K2 and K(SL)3RG(SL)3KGRGDS with 
heparin. The hydrogel chosen for further analysis was K(SL)3RG(SL)3KGRGDS with heparin in 
PBS at final concentrations of peptide at 1% by weight and heparin at 1 mg/mL Heparin 
contributed to hydrogel stabilization, and the storage modulus in the resulting hydrogel was 
determined at 505 Pa. 
In a next step, we wanted to assess binding and release of VEGF from heparin-
containing hydrogels. Recombinant human vascular endothelial growth factor (VEGF) 
(SIGMA-Aldrich, St. Louis, MO), was incubated with the heparin solution for 30 min at room 
temperature prior to mixing it with the peptide stock. Hydrogels were seeded into 96-well 
plates at a volume of 100 uL per well, with final concentrations of 1 mg/mL of heparin and 
10 ng of VEGF per gel. After 30 min of equilibration, 200 u± PBS containing 1% BSA were 
added on top of each gel. Control gels were prepared with VEGF in PBS without heparin. 
Gels for both groups were seeded in triplicates for growth factor release to be measured 
over 14 days of incubation at 37°C. For sample collection, the supernatant from each gel 
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was removed and stored at -80°C, and new supernatant was added. After 14 days, VEGF 
content was measured in all samples using a VEGF ELISA kit (Quantikine Human VEGF 
Immunoassay, R&D Systems, Minneapolis, MN). VEGF concentrations were calculated 
based on standard samples, and the percentage of daily VEGF release was calculated and 
plotted in Figure 24. 
Time [Days] 
release is observed for gels prepared with PBS. 
Figure 24: VEGF 
release profile. Release 
of VEGF from MDP 3E 
with heparin (blue) and 
control gels with PBS 
(black). Data points 
and error bars show 
mean values and 
standard deviations (n 
= 3). Heparin retains 
VEGF in the gel with a 
slowed release, where 
50% of VEGF are still 
14 bound after 1 week. In 
contrast, a burst 
Slowed release of VEGF from heparin-containing gels could be observed, where 50% of 
VEGF are still bound after 1 week, whereas VEGF in control gels is depleted by 90%. 
In heparin-containing hydrogels, PBS is interchangeable with p-glycerophosphate in 
water containing 298mM sucrose, resulting in an equally stable gel. These promising results 
allowed us to incorporate two bioactive factors, VEGF to induce angiogenesis and 0-
glycerophosphate to promote mineralization, into a hydrogel permissive for cell adhesion 
and cell-mediated degradation. An in vitro compatibility check with dental stem cells was 
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the last step that had to be performed before applying these customized hydrogels in an in 
vivo setting. 
4.7. In Vitro Study with Dental Stem Cells 
To assess the behavior of dental stem cells in the established system, both SHED and DPSC 
were seeded into hydrogels of K(SL)3RG(SL)3KGRGDS containing 3-glycerophosphate and 
VEGF. Whereas VEGF was not expected to promote dental stem cell differentiation, we 
wanted to test the system exactly the way we planned to use it for the in vivo studies. In 
this case, 5 x 105 of either SHED or DPSC were seeded into 100 u l hydrogels, and medium 
was added on top and changed every other day. After 4 weeks, gels were fixed in 4% PFA 
for 2 hours, dehydrated through ethanol series and embedded in paraffin. Sections were 
prepared at 5 u.m thickness, and mounted to glass slides. Cells and gels were stained with 
H&E, Masson's trichrome (Trichrome Stain (Masson) Kit, Sigma-Aldrich, St. Louis, MO) and 
von Kossa stain to gain information about cellular morphology and distribution, collagen 
deposition and mineral formation. 
Figure 25 displays the results. Both SHED and DPSC were evenly distributed 
throughout the matrix. Whereas SHED showed a more spindle-shaped morphology, DPSC 
appeared mostly round. Collagen deposits could be observed for both cell lines. Von Kossa 
stain revealed that the cells started to form mineral around their cell bodies. 
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Our histologic analysis provides evidence that the cells not only survive in this 
customized synthetic matrix, but that a differentiation process is stimulated, which results 
in collagen deposition and mineral formation. 
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Figure 25: Histologic analysis of SHED and DPSC in a customized multidomain 
hydrogel. The left column shows DPSC (A, C, E), the right column SHED (B, D, F) in MDP 3D. 
DPSC appear round, SHED more fibroblast-like and spindle-shaped (A: H&E, B: Masson's 
Trichrome). Both cell lines deposit clusters of collagen throughout the matrix visible as blue 
deposits around the cell bodies after Masson's Trichrome stain (C, D). The remaining 
hydrogel matrix takes on a light blue color. Mineral formation can be seen as dark brown 
stain after von Kossa (E, F). 
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Looking back at the data acquired in Specific Aim 1 and 2, we certainly had 
numerous ideas for further optimization and customization of this system. The effect of 
RGD ligand densities on dental stem cells could be assessed, and alternative cleavage motifs 
might be tested. The influence of the mechanical properties of the hydrogels on dental 
stem cell migration and differentiation could be evaluated. It has been demonstrated for 
osteoblasts that stiffness of the matrix alone can affect cellular differentiation [105, 106]. 
Effects on dental stem cells could be similar, given the close relatedness of the osteoblast 
and odontoblast lineages. 
Series of tests to evaluate the optimal concentrations of heparin and VEGF for 
prolonged release would be a next step. Additional growth factors could be included, such 
as basic fibroblast growth factor (FGF-2) or transforming growth factor beta (TGF-(3), which 
have been shown to increase proliferation rates of dental stem cells and promote cell 
differentiation into an odontoblast-like phenotype [107]. Both growth factors can be bound 
via heparin [102]. Another interesting field of exploration would be incorporation of peptide 
sequences which can promote crystal nucleation and mineral formation. Several of these 
sequences have been described in the literature [107 - 109] 
However, with promising results on our hands, we decided to stop the optimization 
process for this project, and apply this scaffold combined with the two dental stem lines in 
our animal studies described in Specific Aim 3. 
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5. Troubleshooting 
5.1. Cell seeding 
For cell proliferation and differentiation assays, cells were cultured in 96-well plates. For 
histology, though, the gels had to be removed from the wells without deformation or 
damage, which turned out to be difficult. Therefore, a new seeding procedure was 
established. The top 3 mm of a 0.5 mL PCR reaction tube were cut to form a small ring of 5 
mm in diameter. These rings were autoclaved, and placed into 6-well plates. The cells and 
gels were then directly seeded into the rings, and these could be removed easily to leave an 
undamaged gel, which was then fixed and processed for histology and only removed from 
the well before transferring the gels to xylene, the last step before paraffin-embedding. This 
procedure worked well, and at the same time, we could make sure that even with high cell 
densities within the gels, nutrients from the cell culture media were available in sufficient 
amounts. Whereas only 200 u l of medium fit on top of a gel in a 96-well plate, the large 6-
well plates allow for much larger volumes of culture medium. 
5.2. Processing for Histology 
For the first experiments with K-series hydrogels, dehydration and paraffin-embedding did 
not work well, and the gels shrank as soon as they were immersed in xylene. Prolonged 
time periods in ethanol series resolved this problem, which was most likely due to 
insufficient dehydration. Whereas 30 min for each dehydration step (50, 70, 80, 90, 95 and 
100 % ethanol) were sufficient for peptide amphiphile gels, K-series peptides were left for 1 
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hour at each concentration, and the last step in 100 % ethanol was repeated. These changes 
made it possible to process and embed these gels and obtain satisfactory results from 
histologic analysis. 
5.3. Heparin Binding 
The induction of gelation using negatively charged heparin proved difficult first, where 
precipitates would form unless the concentration of heparin was low and/or the 
concentration of peptide was high. These first experiments were performed with heparin 
dissolved in water. The idea was that negatively charged heparin molecules could replace 
phosphate ions and induce gelation due to a charge effect. Peptides with two lysines in the 
flanking region (K2(SL)6K2, K2(SL)3RG(SL)3K2) were able to form gels with heparin at a 
concentration of 2-5 mg/mL, but the peptide concentration had to be increased to 2 % by 
weight. With only 1 lysine present (K(SL)3RG(SL)3K), the peptide concentration had to be 
increased even further to 3 % by weight, which posed a problem, since peptides are time-
consuming and expensive to synthesize. For peptides with RGD attached (K2(SL)6K2GRGDS, 
K(SL)3RG(SL)3KGRGDS), gels did not form even at high peptide concentrations. 
However, dissolving heparin in PBS solved this problem, and stable gels could be 
produced for all peptides. In this case, addition of heparin increased gel strength. PBS is 
interchangeable with a solution of B-glycerophosphate at the same concentration. 
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5.4. VEGF Release Study 
An ELISA kit was used to determine the amounts of VEGF released from gels with and 
without heparin. However, these kits are highly sensitive and detect picogram-quantities. 
For the first experiments, the amount of VEGF in the samples was too high, and the 
absorbance readings above the linear range. Test runs were performed to determine 
amounts of VEGF compatible with this ELISA kit. Incorporation of 10 ng of VEGF per gel and 
a 1:2 dilution of the samples resulted in reasonable absorbance readings. 
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CHAPTER VI: SPECIFIC AIM 3 
To test the potential of the generated system for engineering of the dentin-pulp-complex 
in an appropriate animal model. 
1. Summary 
The customized peptide hydrogel system generated in the previous Specific Aims now 
features 1) Sufficient gel strength (storage modulus of approximately 500 Pa), 
2) Shear-thinning behavior, which allows for application with a syringe into small spaces, 
3) The cell adhesion motif RGD, 
4) An MMP-2 specific enzyme-cleavable site, 
5) 3-glycerophosphate as a source of inorganic phosphate for mineralization, and 
6) Vascular endothelial growth factor (VEGF) bound to the hydrogel via heparin. 
Extensive characterization and testing of the hydrogel with dental stem cells in vitro 
yielded promising results. However, to get a realistic idea of the cells' behavior in this 
system, evaluation in an appropriate animal model was necessary. As a first step, we 
needed a carrier to deliver the cell-laden hydrogels. To mimic the clinical situation, we 
chose to use standardized dentin cylinders. This environment closely resembles the site 
which the cell-laden hydrogels should be delivered to as part of a novel treatment strategy 
for the regeneration of the dentin-pulp-complex. These dentin cylinders were prepared 
from human molars, and the root canal was enlarged to make space to inject the hydrogels. 
Since our system contains bioactive factors, an ectopic implantation site was desirable, 
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where nutrients to the cells would be provided without induction of differentiation by the 
host tissue. Therefore, the cylinders were implanted subcutaneously in the back of 
immunodeficient mice. Both cell lines in hydrogels with and without bioactive factors 
should be tested, with cell-free cylinders as controls, resulting in a total of six groups. The 
progress of tissue formation was evaluated by harvesting implants after 2 and 5 weeks. Six 
implants were placed per group and time point. After implant retrieval, the cylinders were 
fixed, demineralized and prepared for histologic analysis and immunohistochemistry. 
Whereas only remnants of the empty hydrogel were present in control cylinders 
without cells, both SHED and DPSC had formed cellular networks within the cylinders after 
two weeks. Without VEGF, tissue formation was limited to the entrance of the cylinders, but 
empty hydrogel was found in the midsection. With VEGF, the united cell structure reached 
further into the canal. Microvessel counts revealed significantly more blood vessel 
formation in VEGF-containing hydrogels. 
After 5 weeks, the cylinders with growth factor-containing gels were filled with 
vascularized connective tissue resembling its physiological counterpart. The hydrogel was 
replaced by natural extracellular matrix. For DPSC, few small and dense collagen deposits 
could be observed throughout the newly formed tissue. After immunohistochemistry for 
localization of dentin sialoprotein (Dsp), a dentin-specific protein, small Dsp-positive islands 
could be detected in DPSC-containing constructs. Collagen deposition and Dsp expression 
indicate that the cells undergo a differentiation process. However, the deposits and Dsp-
positive cells were not predominantly found towards the interface of cells and dentin, but 
throughout the matrix. 
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Our results provide evidence that both dental stem cells lines delivered in customized 
multidomain peptide hydrogels are suitable for a treatment strategy to regenerate dental 
pulp. VEGF proved to be a potent stimulator of microvessel formation and enabled tissue 
formation throughout the length of the cylinder. However, directional deposition of 
collagen as a template for mineralized dentin remains to be resolved. 
2. Materials and Methods 
2.1. Treatment Groups 
To test both dental stem cell lines with peptide-based hydrogels with and without bioactive 
factors, six groups were established (Table 2). Our goals were as follows: 
1) To evaluate the amount and quality of new tissue formed by SHED or DPSC cells, and 
to compare the two cell lines regarding cell densities, cell morphology, connective 
tissue formation and collagen deposition within the dentin cylinders. 
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2- and 5 weeks 
18 
Table 2: Treatment and control groups for implantation 
MDP 3D: K(SL)3RG(SL)3KGRGDS SHED: stem cells from human exfoliated deciduous teeth 
GF = Growth Factor DSPC: dental pulp stem cells 
VEGF = vascular endothelial growth factor P-GP = P-glycerophosphate 
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The decision to place six implants per group was based on previous studies [65, 110], and 
on consultation with Dr. Scott Baggett at the Department of Statistics at Rice University. A 
post hoc power analysis on data for new blood vessel formation obtained from the two-
week experiments confirmed that the number of samples per group was sufficient to detect 
statistically significant differences between treatment groups with a confidence > 95 % (a 
<= 0.05). 
Six implants were placed per group, and four implants were transplanted into each 
animal, which amounted to a number of 36 implants per time point, 72 implants in total, 
and a total number of 18 animals. 
2.2. Implant Preparation 
Since our cell delivery system is not a solid material, a suitable carrier system for 
implantation had to be chosen, which would provide stability and allow for implant 
localization and retrieval after several weeks in situ. Hydroxyapatite powder was an option 
we considered, since this material had been used as a carrier for SHED and DPSC cells in 
previous studies [25, 27]. However, we envisioned an enclosed space, closely mimicking the 
situation of the pulp chamber or root canal. A cylindrical system seemed most feasible. 
Carriers from materials such as polytetrafluoroethylene (PTFA) cylinders or titanium meshes 
were discussed, both of which are commonly used as implant materials in dentistry [111, 
112]. Any material-related effect on the cells had to be avoided, and the carrier should 
allow for histologic analysis of newly formed tissue. Therefore, we chose the natural 
material the cells would be in contact with in a clinical setting: dentin. 
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2.3. Dentin Cylinders 
Extracted human teeth were collected by local oral surgeons and stored in 0.5 % chloramine 
(chloramine T hydrate, SIGMA-Aldrich, St. Louis, MO; in de-ionized water) at 4°C to avoid 
bacterial growth and contamination. Dentin cylinders were prepared from the roots of 
molars using a low speed handpiece and a cylindrical diamond bur (diameter 12 mm) under 
constant irrigation with water for continuous cooling, as depicted in Figure 26. The size of 
the cylinders was designed to be small enough for implantation, yet hold a volume of 
hydrogel of at least 20 u l . Therefore, cylinders were prepared at a height of 4 mm, an inner 
diameter of approximately 1.5 mm and an outer diameter of 3 mm (volume = 0.028 cm3 or 
28 u±). The root canal was enlarged to prepare the shape of a hollow tube. After 
preparation of the cylinders, these were stored in chloramine at 4°C until further use. The 
teeth and cylinders were constantly kept in solution or in a moist environment to avoid 
drying effects. 
92 
Before cell seeding, the dentin cylinders underwent several steps of a preparatory 
procedure, which was carried out in a sterile tissue culture cabinet. The cylinders were 
washed in PBS three times for 1 min per wash, followed by 10 minutes in 5% sodium 
hypochlorite for disinfection purposes. This procedure was chosen over autoclaving, which 
has been described to sterilize dentin disks [113]. The goal was to preserve the growth 
factors which are entrapped in the dentin matrix [54,114]. 
After disinfection, the cylinders were washed in PBS three more times, and etched 
with 10% citric acid for 1 min, followed by three final washes in PBS. Etching demineralizes 
the dentin surface and exposes the collagen fibrils, which is a well-documented 
phenomenon, as this procedure is a critical step during the procedure of bonding resin-
based dental filling materials to the dentin surface [115]. Furthermore, etching releases 
growth factors entrapped in the dentin matrix and it has been shown that these stimulate 
matrix secretion and odontoblast differentiation [49]. After seeding of dental stem cells in 
pretreated cylinders, collagen could promote cell attachment and growth factors could aid 
in cellular differentiation. The dentin surface could thus provide directionality, ideally 
resulting in deposition of new predentin towards the existing walls. 
2.4. Hydrogel Preparation and Cell Seeding 
A peptide solution from MDP 3D at 2% by weight was prepared in water containing 298 mM 
sucrose. The peptide stock was mixed with either one of the following solutions: 
A) PBS containing 2 mg/mL heparin (for GF-free control groups 1, 3 and 5) 
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B) De-ionized water containing 2 mg/mL heparin, 298 mM sucrose, 
10 mM B-glycerophosphate, and 200 ng/mL VEGF (for groups 2, 4 and 6). 
Solution B was prepared 30 min prior to seeding to allow for VEGF-heparin binding. 
Subconfluent SHED and DPSC of passage 4 were detached, counted on a 
hemocytometer, and resuspended in either solution A or B at a cell density of 2.0 x 107 cells 
per mL. Hydrogels with and without cells and bioactive factors were prepared, and 
approximately 30 +/- 5 u l of hydrogel were pipetted into each dentin cylinder. The final 
concentrations were: 
A) 1 mg/mL heparin; 149 mM sucrose, 0.5 x PBS 
B) 1 mg/mL heparin, 298 mM sucrose, 0.5 mM B-glycerophosphate, 100 ng/mL VEGF. 
The cell number per cylinder amounted to 3 x 105 cells. 
The hydrogel-containing cylinders were placed into petri-dishes, and cell culture 
medium was added to cover the bottom of the plate and maintain a moist environment. 
The cylinders were stored at 37°C in a 5% C02 environment until preparations for the 
surgical procedure were complete, usually not more than 30 min. 
2.5. Transplantation Procedure 
Immunodeficient mice (8-to 10-week-old females, strain Crl: NM-Lyst bgFoxnlmBtkM or NIH 
III; Charles River, Wilmington, MA) were used as subcutaneous transplant recipients 
according to specifications of an approved small-animal protocol (National Institute of 
Dental and Craniofacial Research). Operations were performed under anesthesia achieved 
by intraperitoneal injection of 0.35 - 0.4 mL of a mixture of ketamine/xylazine at 50/5 
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mg/kg. Four midlongitudinal incisions of approximately 0.5 mm in length, two on each side, 
were made on the dorsal surface of each animal. Subcutaneous pockets were created by 
blunt dissection, and one implant was placed per pocket, four implants per animal. Incisions 
were closed with surgical sutures. Local anesthetic (0.5% marcaine at < 0.5 mL/kg) was 
injected subcutaneously after surgery and once every day for the following three days as 
part of post-surgical care. 
2.6. Implant Recovery and Processing 
Implants in situ and after explantation are depicted in Figure 27. Animals were sacrificed 
two or five weeks after implantation. The implants were retrieved, briefly washed in PBS 
and fixed in 4% buffered paraformaldehyde (PFA) solution overnight at 4°C. After several 
washing steps in PBS, the implants were transferred to a Morse's demineralization solution 
containing 22.5% formic acid and 10% sodium citrate, which has been shown to preserve 
antigenic sites [116]. The dentin cylinders were decalcified at room temperature on a 
shaker at 60 rpm for 6 days, and the solution was changed daily. The required time for 
sufficient demineralization, after which the dentin no longer offered resistance to cutting 
with a blade during sectioning, was determined prior to implantation on test cylinders. 
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Figure 27: implants in situ, after explantation and during processing. Four implants per 
animal were placed subcutaneously into immunodeficient mice (A). The tissue that formed in 
hydrogels without VEGF appeared pale (B), in VEGF-containing hydrogels reddish (C). The 
dentin cylinders were transferred into glass vials for fixation and processing (D). 
After demineralization, the implants were processed through ethanol series for 
dehydration for a minimum of 1 hour per step at 4°C. The constructs were then embedded 
in paraffin, sections of 8 |im thickness were prepared on a microtome, and mounted to 
glass slides (Superfrost/Plus, Fisher Sci, Pittsburgh, PA). 
2.7. Histology and Immunohistochemistry 
Sections were deparaffinized in xylene and rehydrated though ethanol series. For histology, 
the tissues were stained with hematoxilin and eosin (H&E), and Masson's Trichrome to 
visualize collagen formation, (Trichrome Stain (Masson) Kit, Sigma-Aldrich, St. Louis, MO). 
To localize microvessels in the newly formed tissues, a dilution of 1:100 of a 
polyclonal rabbit-anti-human Factor VIM antibody (Lab Vision, Fremont, CA) was used as 
described previously [65]. Color development was performed with Dako EnVision + system 
kit (AEC, Dakocytomation), and sections were counterstained with hematoxilin. For 
controls, one section per group was treated with PBS instead of primary antibody. 
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The number of microvessels was counted in 2 sections of each of the 6 implants per 
group, resulting in a total count of 12 sections per treatment condition. Microvessels were 
identified at 20 x magnification under a light microscope. 
For dentin sialoprotein (Dsp), a 1:100 dilution of anti-human Dsp antibody was used, 
which was kindly provided by Dr. Larry Fisher at the NIH. Color development was performed 
as described above. 
2.8. Statistical Analysis 
To determine differences between groups treated with and without VEGF, paired student's 
t-test was performed to compare group 1 vs. 2, 3 vs. 4 and 5 vs. 6 at a significance level of a 
= 0.05. Means and standard deviations were calculated, and power analysis was conducted 
for two-week samples to calculate the minimum sample size required to accept the 
outcome of statistically significant differences at a 95% confidence level. 
3. Results and Discussion 
The overall strategy for dentin-pulp-complex engineering in this approach consists of 
manufacturing a root-canal-shaped dentin cylinder filled with a peptide-based hydrogel 
laden with dental stem cells and bioactive factors. These constructs were implanted 
subcutaneously into immunodeficient mice. Ideally, we expected to create a vascularized 
soft connective tissue, degradation of the hydrogel matrix and replacement with natural 
extracellular matrix, a cell-rich zone adjacent to the dentin wall, collagen deposition 
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towards the existing dentin wall as template for mineralized dentin, and Dsp-positive cells 
lining the predentin front. 
Following implant retrieval, we wanted to assess the amount and quality of new tissue 
formed by SHED or DPSC, and to compare the two cell lines regarding cell densities, 
connective tissue formation and collagen deposition within the dentin cylinders. 
Furthermore, we wanted to evaluate if the presence of vascular endothelial growth factor 
(VEGF) can aid in the establishment of microvascular networks, which is of crucial 
importance for tissue vitality. Histologic stains provided information about overall tissue 
structure, and the formation of collagenous networks. Immunohistochemistry allowed for 
the visualization and quantification of newly formed microvessels within the dentin 
cylinders, and for identification of differentiated cells expressing dentin sialoprotein, a 
protein specifically expressed by dentin-forming odontoblasts. 
3.1. Results after 2 Weeks 
Figures 28 and 29 show images of the constructs after two weeks in situ. In cell-free 
constructs, only remnants of the gel, but no cells were present for both groups 1 and 2 (28 
A). When cells, but not bioactive factors were present, tissues formed on either side at the 
opening of the cylinders, whereas the midsections remained empty (28 B). However, the 
presence of VEGF seemed to result in better nutrition, allowing the cells to survive 
throughout the length of the cylinder (28 C). This effect could be observed for both cell 
lines. 
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A higher density of blood vessels inside the cylinders in the presence of VEGF was 
confirmed after microvessel counts. Two examples after immunohistochemical staining for 
Factor VIII are depicted in Figure 30. For both SHED- and DPSC-laden cylinders, significantly 
higher numbers of microvessels between constructs with and without VEGF were observed. 
Our sample size of 6 per group was sufficient to validate statistical significance with 95 % 
confidence (a <= 0.05). For cell-free cylinders, significantly more microvessels were counted 
at the entrance of the cylinders when VEGF was present, whereas the inside of the cylinders 
remained empty in both cases. 
At the interface between dentin and tissue, some areas revealed higher cell 
densities towards the dentin wall (29 C, D, F), which might be due to the suggested effects 
of collagen exposure and growth factor release at the dentin surface. However, it was 
difficult to localize and analyze these areas. In many cases, processing of the tissues 
resulted in an artificial gap between the dentin wall and the tissues. Remnants of the gels 
could be observed for groups 3-6, in areas of high cell density, these were enclosed by cell 
clusters (28 E, F). In DPSC-laden constructs, small collagen deposits could be observed in 
bioacive-factor-containing gels. For groups 4 and 6, characteristics of physiological pulp 
tissue could be observed, including a cell-rich zone at the dentin-pulp-interface (29 C, D), 
less densely packed fibroblast-like cells making the bulk of the tissue (29 F), and the 
presence of microvessels (28 F, black arrows). The typical odontoblast phenotype present in 
dental pulp could not be observed. Morphological characteristics of mature odontoblasts 
include a columnar shape, a polarized position of the nucleus, and a cellular process 
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Figure 28: Empty cylinder and cylinders with SHED after 2 weeks. 
(A) Overview of a cylinder, arrows indicating the dentin walls. Implantation of cell-free 
hydrogels (group 1) renders remnants of the gel only, the immigration of host cells 
cannot be observed. H&E. 
(B) SHED in hydrogels without growth factors (group 3) survive only towards the opening of 
the cylinder, the mid-section remains cell-free, presumably due to insufficient blood 
vessel formation and therefore lack of nutrients in the center. Arrows indicate the 
demarcation line. Islands of remaining hydrogel can be seen (arrowheads) H&E. 
(C) The presence of VEGF allows for better nutrition (group 4), and cells can be observed 
throughout the cylinder. Arrows show cell clusters. The dentin walls of the cylinder stain 
blue for the collagen matrix left after demineralization. Masson's Trichrome. 
(D) Tissue formation of SHED cells in hydrogels with growth factor (group 4). Small hydrogel 
remnants are still present (arrows); microvessels have formed and can be seen 
throughout the construct (arrowheads). H&E. 
(E) Small hydrogel remnants enclosed by the cells visualized at higher magnification. H&E. 
(F) Gel remnants visible in homogenous blue after Masson's Trichrome (arrows, black). 
Newly formed, wavy collagen fibers have been deposited by the cells, replacing the 
hydrogel carrier (arrowheads). Microvessels filled with erythrocytes (red) can be 
distinguished. Masson's Trichrome. 




Figure 29: DPSC after 2 weeks. 
(A) DPSC in gels with growth factors (group 4). As observed with SHED, in the presence of 
VEGF, cells can be found throughout the cylinder. Masson's Trichrome. 
(B) Higher magnification of the previous image. Single cells are spread out throughout the 
hydrogel matrix (arrows). The appearance differs from SHED at this time point, which 
are much more clustered together (compare Fig. 28 C). Masson's Trichrome. 
(C) Cell-dentin interface. The top part of the image shows the collagenous matrix left after 
demoralization, with a recognizable tubular structure. Adjacent to the dentin wall, a 
zone of higher cell density can be observed, indicating cell clustering towards the dentin 
wall (arrowheads). H&E. 
(D) Consecutive section of (C). The tubular structure of the dentin can be recognized better 
compared to the previous image. Cells cluster at the cell-dentin interface (arrowheads). 
Furthermore, a collagen deposit can be seen at the lower left corner, which can be 
distinguished from the hydrogel matrix by its darker blue color and dense structure. 
Several smaller collagen deposits can also be observed in the zone of higher cell density. 
However, a columnar, polarized appearance resembling odontoblasts cannot be 
confirmed. Masson's Trichrome. 
(E) Higher magnification of a collagen deposit (arrows); these can be observed throughout 
the matrix for DPSC (group 4), but not for SHED (group 6). Masson's Trichrome. 
(F) Connective tissue reminiscent of dental pulp. The wall of the dentin cylinder can be seen 
on the right hand side. A zone of more densely packed cells appears at the cell-dentin 
interface. Microvessels have formed and can be seen throughout the tissue (arrows). 
Cells show a fibroblast-like morphology. H&E. 
d: dentin. 
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3.1.3. Microvessel formation 
Figure 30: Localization of microvessels by immunohistochemistry. Example slides for 
visualization of microvessels using Factor VIII antibody. Endothelial cells appear in dark red 
(arrows). 
Figure 30 demonstrates visualization of microvessels after immunohistochemistry with 
Factor VIII antibody, which was performed for both cell lines. Factor VIII is a glycoprotein 
present in endothelial cells, which is released into the blood stream after activation of the 
clotting cascade to aid in hemostasis, and its presence identifies endothelial tissue. This 
method of detection and subsequent counts of vessels in tissue sections was performed 
after modification of a protocol described in a similar study with SHED in tooth slices [65]. 
The authors investigated the intrinsic potential of SHED to form microvessels, and they 
compared SHED alone to SHED mixed with human endothelial cells. Two aspects of this 
work are highly interesting. Co-transplantation of SHED with endothelial cells did not result 
in higher blood vessel density in these constructs. Furthermore, SHED cells were transduced 
with LacZ before implantation to evaluate cell fate in the constructs. The majority of blood 
vessels in the constructs stained positive for LacZ, indicating that SHED cells had 
differentiated into endothelial cells and contributed to microvessel formation. In our study, 
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we did not investigate the origin of endothelial cells in our constructs. The newly formed 
microvessels could therefore be of murine origin, but also very well be formed by the 
implanted cells, as indicated by the results described above. 
Another aspect, comparing our work to CORDEIRO's [65] is that the tooth slices used for 
cell seeding in their case were 1 mm thick, allowing connection to the local vasculature 
more easily. In our work, the cylindrical shape of the constructs makes proper nutrition of 
the implanted cells more challenging, a fact that bioengineers will face trying to re-colonize 
the long and narrow space of a root canal with live tissue, which will inevitably depend on 
sufficient provision of nutrients to the cells. Our results of higher microvessel density and 
formation of dental-pulp-like tissue in those cylinders mediated by VEGF are promising and 
make this growth factor a prime candidate for future strategies to engineer dental pulp. 
3.2. Results after 5 weeks 
3.2.1. Emtpy Cylinders 
After 5 weeks in situ, the empty cylinders are unaltered and only show remnants of the 
hydrogel, and encapsulation by fibrotic host tissue, which can be seen in Figure 31. From 
visual inspection, no difference could be observed between groups 1 and 2. 
105 
tissue has formed around the implant (arrows). Masson's Trichrome. 
d: dentin 
3.2.2. SHED 
Figure 32 depicts images from transplanted SHED. Without growth factors in the hydrogel, 
the cells form tissue to some extent, but large areas containing vacuoles reminiscent of fat 
tissue are present (32 A), and big remnants of hydrogel can be observed (32 B). However, 
small areas of pulp-like tissue can be found, and a collagenous matrix is formed (32 D). In 
growth-factor containing gels, the areas of pulp-like tissues are much larger (32 E). Dense 
cellular networks develop for SHED, and these cells synthesize tightly packed collagen (32 E, 
F). High proliferation rates of SHED have been reported before [25], and our own work in 
peptide amphiphiles demonstrated that these cells grow faster in the hydrogel matrix 
compared to DPSC, and deposit more collagen [84]. 
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Figure 32: SHED after 5 weeks. 
(A) Tissues in cylinders without growth factors consist mainly of vacuoles reminiscent of fat 
tissue. H&E. 
(B) Large remnants ofhydrogel surrounded by cell clusters can be observed (arrows). H&E. 
(C) Between large areas of vacuoles and non-degraded hydrogel, small areas show an 
organization similar to connective tissue, where the hydrogel has been replaced by 
collagen fibers, in which the cells are embedded. Masson's Trichrome. 
(D) Higher magnification of C. The cell clusters and collagen fibers in dark blue are visible. 
Masson's Trichrome. 
(E) SHED in hydrogels with growth factors show larger areas of properly organized tissue. 
Predominant formations show a high cell- and collagen-density. Masson's Trichrome. 
(F) Higher magnification ofE. Densely packed collagen matrix. Masson's Trichrome. 
d: dentin; h: hydrogel, v: vacuoles 
3.2.3. DPSC 
Compared to SHED, the tissues formed by DPSC resemble more closely dental pulp tissue. 
The cells form a lose network (33 A, B), and at the interface between dentin and tissue, an 
intimate association between cells and dentin can be observed (33 A-D). However, in some 
areas larger cells similar to osteoclasts can be observed, and a rugged dentin might be the 
result of a resorption process (33E). 
The synthetic matrix is replaced by collagen, in most areas appearing like an 
extracellular matrix, in which the cells are embedded (33 B, D). Apart from that, localized, 
small and very dense collagen deposits can be observed (33 D). These are usually found in 
close vicinity to microvessels. These dense deposits can be found only in DPSC in hydrogels 
with growth factors present. One might speculate whether VEGF plays a role, given their 
association with microvessels, but the B-glycerophosphate might have an inductive effect, 
too. Although it is mainly believed to aid in mineral formation, it has been associated with 
stem cell differentiation as an osteogenic supplement. Unfortunately, after 
demineralization of the constructs detection of mineral is no longer possible. 
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Figure 33: DPSC after 5 weeks. 
(A) Properly organized tissue highly similar to dental pulp can be found. The cells are 
embedded in a lose network of collagen, and they line the walls of the cylinder, tightly 
associated with the dentin. 
(B) Higher magnification of A. 
(C) The cells are packed more tightly towards the dentin. The columnar, polarized cell shape 
of mature odontoblasts cannot be observed. 
(D) Small and dense collagen deposits can be found, usually in close vicinity to microvessels 
(arrows). 
(E) The dentin surface appears disrupted, and large cells with multiple nuclei reminiscent of 
osteoclasts appear (arrows), suggesting resorption of the dentin. 
(F) The hydrogel has mainly been degraded, only small remnants can be found (arrows), 
d: dentin. 
Islands of Dsp-positive cells were found in DPSC and differentiation factor-containing 
hydrogels (Figure 34). However, these islands were sparse, and distributed throughout the 
matrix rather than lining the dentin wall, as expected. Still, expression of Dsp in these cells 
demonstrates that they undergo a differentiation process. 
Figure 34: Localization of dentin sialoprotein. 
(A) The dentin cylinder served as a positive control, as Dsp is entrapped within the dentin 
matrix and shows up in dark brown after immunohistochemistry. 
(B) Cell clusters within the newly formed tissue showed Dsp expression (arrowheads) as an 
indicator or cellular differentiation towards an odontoblast-like cell type. 
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Overall, we can show that combining dental stem cells with this customized hydrogel 
results in the formation of a pulp-like tissue. However, the desired tissue formation could 
not be observed in all constructs but in about 50 % of the implants, whereas the rest was 
filled with fibrous tissue and vacuoles or showed areas with gel remnants similar to the 
empty cylinders. Reasons for these differences could be the site of implantation, where 
implants placed directly behind the ears seemed less exposed to movement of the skin, and 
could not be reached by the animals, which tended to scratch at the implantation sites. In 
future work, the implants should be placed as far up and towards the midsection as possible 
to avoid these effects. 
In constructs with proper tissue formation, the hydrogel carrier is degraded and 
replaced by a collagenous extracellular matrix. VEGF aids in quick organization of a 
microvascular network to provide oxygen and nutrients to the cells. Pre-treatment of the 
dentin did not noticeably affect cellular organization and differentiation; however, intimate 
association of the implanted cells with the dentin walls can be seen. Some areas show signs 
of dentin resorption, and cells similar to osteoclasts appear at the cell-dentin interface. This 
unwanted effect could possibly be overcome by pretreatment of the dentin wall. A 
directional deposition of collagen and pre-dentin deposition towards the existing dentin 
walls cannot be observed. 
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4. Troubelshooting 
4.1. Cell Seeding 
Seeding the hydrogel into the small space of the cylinders proved to be difficult at first, 
since bubbles within the cylinder had to be avoided. Using small pipette tips (10 u±), starting 
at the bottom of the cylinder, slowly lifting the pipette as the gels were injected provided 
good results. Repeated centrifugation of the hydrogel/cell stock at 1000 rpm for 30 sec 
between seeding into individual cylinders removed bubbles from the stock, which are 
created during mixing and pipetting. 
4.2. Transplantation 
In general, the animals tolerated the surgical procedure well. One animal was lost 5 days 
after surgery due to a post-surgical infection. One problem we encountered was 
penetration of some of the implants through the skin and partial exposure of the implant 
after a few days in situ, which happened in four cases. Other implants were lost, as the mice 
tended to scratch the incision site and remove the implants. For a total of 10 implants, the 
surgeries had to be repeated. We tried to place the implants as far up and centered on the 
dorsum as possible to keep them out of reach for the animals, and less implants were lost 
after that. 
4.3. Sectioning 
Sectioning of the dentin cylinders proved difficult, as it is for most demineralized tissues. 
Alignment of the cylinders perpendicular to the direction of the blade during cutting made 
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sectioning easier. Not more than two cylinders could be placed into one block to obtain 
sufficient quality of the sections. Keeping the blocks at -20°C before sectioning, and cooling 
the blade with cooling spray (Freeze it, Fisher Sci, Pittsburgh, PA) between sections helped 
to improve the quality of the sections. 
4.4. Immunohistochemistry 
As typical for immunohistochemistry, the optimal protocol had to be developed for both 
antibodies. Different dilutions of primary antibody were tested (1:100, 1:250, 1:500) as well 
as different incubation times (30 min, 45 min) and temperatures (RT, 37°) with primary and 
secondary antibody. A dilution of 1:100 for both primary antibodies and incubation periods 
of 45 min at 37° C provided best results. 
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CHAPTER VII: CONCLUSIONS AND FUTURE PERSPECTIVE 
The described system of dental stem cells encapsulated in a multidomain hydrogel scaffold 
laden with bioactive factors for cell differentiation and new blood vessel formation offers great 
promise for future tissue engineering strategies to regenerate dental pulp. 
Multipotent dental stem cells are available from disposable sources, such as baby teeth 
or extracted wisdom teeth, and they maintain their differentiation potential after 
cryopreservation. They have been the focus of commercial stem cell banks as an autologous cell 
source, which can be derived non-invasively and might be useful for a variety of applications. 
Preservation of these cells might become a routine procedure in the near future. 
The peptide-based hydrogel complements these cells for the envisioned treatment 
strategy, as it is compatible with the cells, can be injected into small spaces, and allows for 
custom-made matrices and incorporation of various growth and differentiation factors. In this 
case, (^-glycerophosphate was added to aid in cell differentiation and mineralization, and 
vascular endothelial growth factor stimulated new blood vessel formation. 
Implantation of this system in vivo resulted in the formation of a vascularized connective 
tissue highly similar to dental pulp. Whereas this marks our work as a success, it is only the first 
step in developing bioactive delivery systems designed to serve a specific purpose. Further 
modifications can result in even more sophisticated systems, carrying various growth factors to 
take advantage of potentially synergistic effects. Particularly the possibility of growth factor 
incorporation via heparin should be exploited further. Bioactive peptide sequences for mineral 
nucleation could be inserted, bilayered scaffolds with different properties for soft hard tissue 
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formation are imaginable, or the establishment of growth factor gradients within the gels, to 
name only a few ideas. 
Several challenges in engineering dental pulp remain. In order to regenerate the soft 
tissue within the root canal, a long and narrow space, proper nutrition of the cells is 
paramount. In our model, addition of VEGF allowed for sufficient nutrition at a length of 4 mm. 
Although this result is promising, it has to be demonstrated that longer distances up to 10 mm 
can be bridged. If connection to the vasculature at the apex of the tooth can be achieved, 
engineering of the dental pulp instead of placing root canal fillers might move closer into the 
realm of possible treatment options. 
In order to apply the described system as a pulp capping agent in deep cavities to 
encourage reparative dentin formation, the problem of directional dentin deposition has to be 
resolved. Currently we do not know how to direct dentin formation in a synthetic system. 
However, in a clinical setting, the inflammatory response at the site of injury triggers 
recruitment of progenitor cells, their differentiation and subsequent dentin bridging, which 
separates the soft tissue from the site of injury. It is worthwhile to explore whether dental stem 
cells delivered in a clinical setting can aid in this process and accelerate and optimize healing. 
Whereas these challenges remain, we believe that the first steps we have undertaken 
have the potential to significantly impact further developments in oral healthcare, and might 
also have broader applications to the engineering of other body tissues. 
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CHAPTER VIII: APPENDICES 
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ABSTRACT 
Dental caries remains one of the most prevalent infectious diseases in the world. So far, 
available treatment methods rely on the replacement of decayed soft and mineralized 
tissue with inert biomaterials alone. As an approach to develop novel regenerative 
strategies and engineer dental tissues, two dental stem cell lines were combined with 
peptide-amphiphile (PA) hydrogel scaffolds. PAs self-assemble into three-dimensional 
networks of nanofibers, and living cells can be encapsulated. Cell-matrix interactions were 
tailored by incorporation of the cell adhesion sequence RGD and an enzyme-cleavable site. 
SHED (stem cells from hiuman exfoliated deciduous teeth) and DPSC (dental p_ulp stem cells) 
were cultured in PA hydrogels for four weeks using different osteogenic supplements. Both 
cell lines proliferate and differentiate within the hydrogels. Histologic analysis shows 
degradation of the gels and extracellular matrix production. However, distinct differences 
between the two cell lines can be observed. SHED show a spindle-shaped morphology, high 
proliferation rates and collagen production, resulting in soft tissue formation. In contrast, 
DPSC reduce proliferation, but exhibit an osteoblast-like phenotype, express osteoblast 
marker genes, and deposit mineral. Since the hydrogels are easy to handle and can be 
introduced into small defects, this novel system might be suitable for engineering both soft 
and mineralized matrices for dental tissue regeneration. 
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INTRODUCTION 
In every respect, the field of tooth bioengineering encompasses broad strategies and 
multidisciplinary approaches directed at restoring one of the most complex organ systems 
in vertebrates. Although rather small, a tooth is a composite of three calcified matrices, 
each of which possesses unique biochemical, biomechanical and structural properties. The 
anatomic tooth crown contains the hard tissues enamel and dentin, as well as soft tissue in 
its core, the dental pulp. The root anchors the tooth to the surrounding alveolar bone via 
the tendon-like periodontal ligament, which inserts into the cementum, a thin layer of yet 
another species of mineralized tissue covering the root surface. Enamel is a very hard and 
brittle substance mainly made of inorganic hydroxyapatite; cementum is similar to bone, 
but lacks vascularization. Dentin, a mineralized connective tissue surrounding and 
embedding the dental pulp, exhibits a unique tubular structure. Dentin-producing 
odontoblasts lining the pulp chamber send cellular processes into these tubules, connect 
both tissues to form the dentin-pulp complex, and thus make dentin a live tissue. Exposure 
of dentin after attrition, trauma or carious invasion by bacteria triggers inflammation and 
pain, which upon resolution leads to the recruitment and differentiation of progenitor cells 
and the rapid deposition of a reparative dentin matrix. This active defense mechanism of 
the dental pulp to separate itself from the site of injury and maintain its vitality illustrates its 
strong intrinsic regenerative potential. In recent years the healing capacity of dental pulp 
was underscored by the identification and characterization of populations of postnatal stem 
cells capable of differentiating into odontoblasts. 
Dental tissues harboring stem cells are easily accessible and most often discarded as a 
byproduct of routine surgical treatment. Stem cell characteristics can be detected in cells 
isolated from the pulp of deciduous (1) as well as permanent teeth (2, 3), periodontal 
ligament (4, 5) or periapical follicle (5). Using stem cell markers such as STRO-1 or CD 146, 
mesenchymal stem cells, which represent less than 4 % of the total cell population, can be 
tagged and sorted by fluorescence-activated cell-sorting analysis (1). Tooth-derived stem 
cells are capable of differentiating into adipocytes, neurons and odontoblast-like cells (1, 6). 
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They form mineralized nodules in vitro (5) and create bone or dentin-pulp like complexes 
after transplantation into immunocompromised mice (1, 3). 
As new sources of stem cells are explored and optimal permissive conditions for their 
differentiation are investigated, there is a strong need for advanced biomimetic scaffolding 
materials, which are versatile enough to be targeted for tooth-specific applications. These 
scaffolds have to provide a suitable three-dimensional network to accommodate cells and 
guide their growth, organization and subsequent differentiation. In vivo, these features are 
carried out by the extracellular matrix (ECM). Fibrillar proteins account for most of the ECM 
network, they self-assemble and form a well-organized structure. It surrounds cells, offers 
physical support and specific ligands for cell adhesion and migration. ECM also regulates cell 
proliferation and dynamic characteristics through various growth factors and signaling 
molecules. Recently, a novel class of hydrogel scaffolds has been developed, which offers 
several properties of natural ECM (7-13). These peptide amphiphile (PA) molecules consist 
of a peptide segment coupled to a fatty acid chain; they assemble into three-dimensional 
nanofiber networks to form self-supporting gels. The process is driven by formation of a 
hydrophobic core composed of closely packed alkyl tails, whereby fibrous strands can build 
because of hydrogen bond formation between the amino acids of adjacent PA molecules. 
Long cylindrical structures that are nanometers in diameter and microns in length create a 
gel by trapping water. Whereas the PAs remain amorphous aggregates at neutral pH due to 
the repulsive negative charge, addition of polyvalent ions eliminates the charge and allows 
self-assembly into cylindrical micelles, which undergo physical cross-linking to provide the 
gelled macrostructure. Self-assembly can be triggered upon mixture of PA solutions with 
cell culture media or other physiological fluids that contain polyvalent metal ions. When 
cells are suspended in the fluid, these can be encapsulated in the nanofibrillar matrix. It has 
been shown that cells can move, proliferate and differentiate within the hydrogel (10, 12-
15). Several modifications of PAs have been described in the literature, allowing for mineral 
deposition (16), optimized cell adhesion (11, 17), selective cell differentiation into neurons 
(14) or ectopic bone formation (15). 
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A modification of a PA system that has previously been described was used in this study 
(10). The structure of these molecules can be divided into four regions of function: the 
peptide sequence contains an enzyme-cleavable site composed of GTAGLIGQ; a glutamic 
acid to assist in calcium binding; and RGDS, a cell-adhesion sequence that was first 
described in 1987 (18), which is present in natural ECM and has been integrated into 
various bioengineering scaffolds. The GTAGLIGQ is expected to be cleaved between glycine 
and leucine residues by matrix metalloproteinase 2 (MMP-2). Members of the MMP family 
are able to hydrolyze most of the proteins found in ECM; and MMP-2 is the major matrix 
metalloproteinase expressed by human pulp cells to remodel their environment (19). 
Incorporation of this specific cleavage site is expected to result in cell-mediated proteolytic 
degradation of the network, enabling cell migration and remodeling of the matrix with 
natural ECM. The fourth region of functionality is added after peptide synthesis by N-
acylation with palmitic acid, which provides the driving force for self-assembly. These 
modifications of PA hydrogels are first steps to optimize tissue engineering scaffolds for a 
specific cell type. 
In this study, we tested the use of the PA hydrogel scaffold with the following two well-
characterized postnatal stem cell lines: SHED cells, which were isolated from human 
deciduous incisors (1), and DPSC from impacted wisdom teeth (2, 3). Our goal was to 
explore the compatibility of PA nanofibers with these two cell lines and to assess their 
potential as a suitable scaffold for cell proliferation and differentiation. Combinations of 
dexamethasone with inorganic phosphate ((3-glycerophosphate or potassium phosphate) 
have previously been used as osteogenic supplements, and induced calcium accumulation 
in SHED and DPSC cells (1, 3, 20, 21). Cell differentiation was monitored by alkaline 
phosphatase assay, histologic analysis and quantitative real-time PCR analysis, which 
included marker genes for extracellular matrix synthesis and for differentiated osteoblasts 
and odontoblasts (collagen type I and III, alkaline phosphatase, bone sialoprotein, 
osteocalcin, and Runx2 and dentin sialophosphoprotein). 
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The results of our study show compatibility of both dental stem cell lines with the PA 
nanofibers. Cells spread, proliferate and differentiate within the hydrogels. However, we 
provide evidence that there are distinct differences between the two cell lines and their 
reaction to specific osteogenic supplements. SHED appear more adept for soft tissue 
regeneration, which is enhanced by 3-glycerophosphate, while DPSC have a greater 
potential for terminal differentiation and subsequent mineralization, especially in 
combination with potassium phosphate. The results of this study provide the bases for 
further optimization of PA nanofibers as a scaffold for dental stem cells and for future tissue 
engineering strategies to regenerate dental tissues in vivo. 
MATERIALS AND METHODS 
Preparation of Peptide Amphiphiles 
Peptide amphiphile molecules were synthesized as previously described as a thirteen 
amino-acid peptide (GTAGLIGQERGDS) by standard solid phase chemistry on an Advanced 
Chemtech Apex 396 peptide synthesizer (10). Preparation of the peptide portion was 
followed by acylation of the N - terminus. 150 mg of crude peptide was dissolved in 50 mL 
Dl at pH 7.0. For purification purposes, peptides were precipitated at pH 3, centrifuged 
(4000 rad/min, 5 min), the supernatant was removed and peptides were freeze-dried for 24 
hours. PA stock solution of 2 % by weight was prepared in Dl water by adjusting the pH 
with NaOH to 7.0. PAs were characterized by matrix-assisted laser desorption ionization 
time-of flight (MALDI-TOF) mass spectrometry and were found to have the expected 
molecular weight. Stock solutions were kept under UV-light overnight for sterilization 
purposes. 
122 
Cell Culture of Dental Stem Cells 
Two mesenchymal human stem cell lines were used in this study: DPSC derived from adult 
third molars (3), and SHED cells from exfoliated deciduous teeth (1). Cells were cultured 
with alpha MEM supplemented with 15% fetal bovine serum, 50 u.g/mL L-ascorbic acid 2-
phosphate, 100 U/mL penicillin and 100 |ig/mL streptomycin, and incubated at 37°C with 
5% C02. Subconfluent cells of passage 5 were detached using trypsin EDTA (Invitrogen, 
Carlsbad, CA), and 1.0 x 105 cells were seeded per gel. Therefore, 50 u.1 of PA stock solution 
(2% by weight) were placed in wells of a 96-well plate. Self-assembly into nanofiber 
networks was triggered by addition of 50 u.1 of cell suspension (2 x 106 cells/mL) containing 
0.1 M CaCI2 (pH 7.4). The solution was gently and briefly mixed, and gel formation was 
observed after 2-3 seconds. For each assay to be performed and for each time point and 
culture condition, triplicates were seeded. After 30 min, 200 u.1 of media were added to 
each well. The medium was changed after 24 hrs and osteogenic supplements were added 
according to previous reports (3, 20-22). Three different conditions were established: one 
group of gels was cultured with medium as described above (0 - control), for the second 
group, lOmM 3-glycerophosphate and lOnM dexamethasone (SIGMA-Aldrich, St. Louis, 
MO) were added (0GP + dex); for the third group lOmM potassium phosphate (KH2PO4) 
(SIGMA-Aldrich, St. Louis, MO) and lOnM dexamethasone were added to the media (KPh + 
dex), all of the above being final concentrations. Gels were cultured for up to 4 weeks, 
media was changed every other day, and samples for different assays were collected at 
several time points. 
Measurement ofDNA content 
After 3, 7, 14 and 28 days, cells samples were harvested after enzymatic digestion as 
described above, and cell pellets were frozen down at -80°C for further analysis. After 
completion of sample collection, these were thawed, and assays and measurements were 
performed on all samples at the same time. The number of cells in all samples was 
123 
determined by fluorometric quantification of DNA content using CyQuant cell proliferation 
assay kit (Invitrogen, Molecular Probes, Carlsbad, CA) and a FLUOstar Optima fluorescence 
plate reader (BMG Laboratories, Durham, NC). Actual cell numbers were calculated based 
on a standard curve created from suspensions of known cell densities. 
Alkaline Phosphatase Activity 
Samples for the detection of alkaline phosphatase (ALP) activity were prepared as described 
for the DNA assay. Cell pellets were resuspended in 60 u.1 of PBS. After addition of 60 u.1 of 
alkaline buffer and 100 u.1 alkaline substrate solution (SIGMA-Aldrich, St. Louis, MO), 
samples were incubated at 37°C for 30 min and the liberated p-nitrophenol was measured 
spectrophotometrically at 410 nm. Samples were compared to a dilution series of p-
nitrophenol standard (SIGMA-Aldrich, St. Louis, MO) and ALP activity was normalized to the 
corresponding cell numbers obtained from the proliferation assay. 
Quantitative Real-time PCR 
To assess the effect of osteogenic induction on the expression of genes involved in 
differentiation, matrix formation and mineralization, real-time PCR was performed on 
samples after 28 days of culture. RNA was extracted using RNA Stat 60 (Tel-Test Inc. 
Friendswood, TX) from 6 gels per group at a time to get sufficient amounts for reverse 
transcription, which was performed according to standard protocols for cDNA synthesis 
using an oligo-dT primer. 100 ng of RNA were used for one reaction of reverse transcription, 
which provided cDNA for 10 real-time PCR reactions. Primer sets for marker genes of 
osteoblast and odontoblast differentiation were designed from mRNA sequences published 
in GenBank (identification number given in parentheses) using primer 3 software and 
synthesized as follows: collagen a(l)l (Col I) (NM_000088), collagen III (Col III) (NM_000090), 
alkaline phosphatase (ALP) (NMJD00478), bone sialoprotein (Bsp) (NM_000582), 
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osteocalcin (Oc) (X_53698), Runx2 (NM_004348), dentin sialophosphoprotein (Dspp) 
(NM_014208), matrix metalloproteinase-2 (MMP-2) (NM_004530), and glyceraldehyde 3 
phosphate dehydrogenase (GAPDH) (M_33197) as an internal control. Primer efficiency was 
determined prior to quantification. Conditions for real-time PCR were as follows: After a 
denaturation step at 95°C for 15 minutes, 60 cycles were run with 95°C (15 sec), 58°C (30 
sec), 72°C (30 sec), with a final dissociation step to generate the dissociation profile of the 
PCR products. Experiments were run in triplicates (ABI Prism 7900HT), gene expression was 
quantified using SYBR green (QuantiTect SYBR green PCR kit, Qiagen Inc. Valencia, CA) and 
normalized to GAPDH activity in respective samples. Calculations of fold-change in gene 
expression between controls and treated samples were performed according to the Pfaffl-
method for relative quantification in real-time PCR as described in 
http://pathmicro.med.sc.edu/pcr/realtime-home.htm. 
Histologic analysis 
For histological analysis, gels after 28 days in culture were fixed in 4% paraformaldehyde for 
3 hrs, dehydrated through ethanol series, embedded in paraffin and sectioned at 5 urn 
thickness. Sections were stained with hematoxylin and eosin (H&E), Masson's trichrome 
for collagen detection and von Kossa stain for calcium deposition using standard methods. 
Cryo-transmission electron microscopy (cryoTEM) 
To further investigate the mineralization properties, cryoTEM analysis was performed for all 
groups and samples. Three samples per cell line and condition were cultured as described 
above. As a cell-free control, additional gels were incubated with osteogenic supplements 
for 4 weeks. A small quantity of the sample solution (2-3 u.1) was applied to a TEM copper 
grid with holey carbon film purchased from Quantifoil (400 mesh Cu grid, 1.2 urn hole 
diameter), and blotted with filter paper using a Vitrobot type FP 5350/60 under 100% 
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relative humidity for two seconds to create a thin layer of sample on the surface of the grid. 
The grid was plunged into liquid ethane and quickly transferred to liquid nitrogen. The 
sample was then analyzed using JEOL 2010 TEM at an accelerating voltage of 200 kV under 
low-dose imaging conditions. 
RESULTS 
Cell proliferation 
When embedded in 3D peptide-amphiphile hydrogels, SHED cell proliferation was markedly 
higher as compared to DPSC. Addition of |3GP + dex resulted in slightly increased 
proliferation rates in both cell lines, whereas KPh + dex showed attenuated cell growth. The 
DNA assay yielded corroborative data. After 28 days, cell numbers of SHED were close to 4 x 
105 cells when cultured with PGP + dex, DPSC did not exceed 1.5 x 105 cells per gel. Growth 
curves under different culture conditions as well as actual cell numbers for different time 
points for both cell lines are shown in Figure 2. 
Differentiation of dental stem cells with different culture conditions 
Quantitative measurements of ALP activity showed differences between the two cell lines 
as well as between groups treated with different osteogenic media. The general trend 
shows a dramatic increase in both cell lines over time. SHED responded to treatment with 
PGP + dex with a considerably higher enzyme activity compared to controls, whereas KPh + 
dex seemed to have to opposite effect. DPSC showed a different profile, where KPh+ dex 
evoked slightly higher ALP levels than PGP + dex. 
Analysis of marker genes for osteoblast and odontoblast differentiation (Fig. 3) revealed 
increased expression levels for all the genes investigated after 28 days in culture, with one 
exception, DPSC ceased to express dentin-specific Dspp after treatment with KPH + dex. In 
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SHED, higher expression levels of genes coding for extracellular matrix components (Col I, 
Col III) could be observed, especially with BGP + dex, and levels of MMP-2 were noticeably 
elevated. SHED treated with KPh + dex show an increase in osteoblast marker genes, such 
as bone sialoprotein, osteocalcin and Runx2. The prominent finding for DPSC is that when 
cultured with KPh + dex, the genes involved in the mineralization process, namely alkaline 
phosphatase, bone sialoprotein and osteocalcin, show a substantial increase, which is 
higher than in SHED. 
Histologic analysis revealed degradation of the PA gel (Fig. 4A) and replacement with 
extracellular matrix as observed by Masson's trichrome (Fig. 4B, C). Whereas SHED formed 
clusters of cells (Fig 4 A, B), DPSC were more sparsely distributed within the gel (Fig. 4C), 
they showed a round, osteoblast-like morphology, and mineral deposition with both 
osteogenic supplements, but to a higher degree with KPh + dex (Fig. 4D). SHED treated with 
BGP + dex did not produce mineral deposits, but few deposits were visible for cells treated 
with KPh + dex after von Kossa stain (data not shown). 
Vitreous ice cryoTEM was performed on the PA scaffold surrounding the cultured cells. 
Mineralization of the artificial matrix was observed mirroring the mineralization observed 
by histology. cryoTEM images revealed little mineral deposition for SHED cultured with 
BGP + dex (Fig. 5B), but a slightly higher mineralization rate with KPh + dex (Fig. 5C). 
Mineralization potential in DPSC is much higher, BGP + dex induces deposition mainly of 
larger crystals (Fig. 5E), whereas potassium phosphate appears to be most conducive for the 
formation of multiple mineral deposits (Fig. 5F). Control gels with cells cultured with regular 
media (Fig. 5A, D) or gels incubated with osteogenic supplements for an equivalent period 
of time without cells (images not shown) did not show mineral deposits. 
DISCUSSION 
In this study, we present an in vitro system in which we combined nanofibrous peptide-
amphiphile hydrogels with two adult tooth-derived mesenchymal stem cell lines. Our data 
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provides evidence that these cells are able to 1) proliferate within the gel, 2) remodel it by 
enzymatic degradation and deposition of a collagenous matrix, 3) change their morphology 
and gene expression profile as a sign of differentiation, and 4) deposit calcium and form a 
mineralized matrix. All these characteristics vary between the two cell lines as well as 
between groups treated with different osteogenic supplements. SHED maintain a high 
proliferation rate and a spindle-shaped, fibroblast-like morphology. They produce large 
amounts of collagen, which goes hand in hand with a higher MMP-2 activity as an indication 
of matrix degradation and remodeling; and they form coherent soft tissues during a four-
week culture period. 0-glycerophosphate with dexamethasone enhances proliferation and 
induces upregulation of early differentiation markers such as collagen and alkaline 
phosphatase. In contrast, potassium phosphate and dexamethasone slightly decrease 
proliferation and affect the expression of markers of terminal differentiation of cells 
involved in biomineralization. These include Runx2, Bsp and Oc. DPSC growth is significantly 
slower in the three-dimensional environment compared to SHED. Histological images and 
the change in gene expression after 4 weeks suggest that these cells can be driven further 
towards terminal differentiation, but adopt an osteoblast-like phenotype displaying a round 
morphology, significant upregulation of osteoblast markers, downregulation of Dspp, and 
calcium deposition, especially if cultured with potassium phosphate. cryoTEM analysis 
shows that mineral deposition occurs on the synthetic peptide-amphiphile matrix in a cell-
mediated fashion. The extent of mineralization observed by TEM on the PA matrix mirrors 
the extent of mineralization observed by histology in deposited natural ECM. Importantly, 
this mineralization does not occur in the absence of cells. 
Our data are in accordance with the established model for terminal differentiation where 
cells exit the cycle and cease to proliferate. They are also consistent with previous findings, 
where SHED cells were described to be distinct from DPSC regarding their higher 
proliferation rates and differences in differentiation potential in vitro, which led to the 
conclusion that they might represent a more immature population of stem cells (1). 
Furthermore, our observations reflect the behavior of these cells in vivo and the differences 
regarding their mineralization potential in deciduous and permanent teeth. Clinical studies 
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have shown that pulp capping after exposure of the soft tissue in primary teeth shows high 
failure rates (23). In permanent teeth, reparative dentin formation after application of 
calcium hydroxide has been reported in numerous studies (24). However, formation of 
dentin with its unique tubular structure can only be observed if the odontoblast layer 
remains intact, destruction of these cells leads, in many cases, to deposition of an osteoid 
matrix by replacement cells. Whereas bone and dentin are similar in their matrix protein 
composition, and osteoblasts and odontoblasts are closely related lineages, their organ 
structure, cell phenotype and gene expression profile are distinct. However, the detailed 
mechanisms underlying the initiation and maintenance of an osteoblast- versus an 
odontoblast-like phenotype remain to be elucidated. The conditions used in this study seem 
to favor a differentiation pathway towards the osteoblast lineage. Although both stem cell 
lines have been shown to differentiate into odontoblasts in vivo, the optimum permissive 
conditions for odontoblast differentiation in vitro have yet to be clarified. Growth and 
differentiation factors such as dexamethasone, TGF3-1, different BMPs, Dmp-1 or a mixture 
of dentin non-collagenous proteins have yielded differentiation of cells into odontoblasts in 
vitro (25-28). In this study, the cell culture medium was supplemented with dexamethasone 
to induce cell differentiation, and inorganic phosphate to enhance the mineralization 
process. 
Our data leads to the conclusion that PA molecules provide a nanostructured, cell-
responsive matrix that is specifically conducive to dental stem cells. The hydrogels are easy 
to handle, and due to their mechanical properties they could be inserted into small defects, 
such as cavities of periodontal pockets, without difficulties. The two cell lines seeded in PA 
hydrogels show differences in morphology, proliferation and differentiation behavior. SHED 
seem to be a suitable tool for soft tissue regeneration, such as dental pulp, whereas DPSC 
might be useful for engineering mineralized tissues like bone or dentin, which can be 
enhanced by the choice of osteogenic supplement. This research may provide us with an 




(A) Chemical structure of the peptide amphiphile, highlighting the four regions of function: 
1) alkyl tail, 2) enzyme-cleavable site, 3) glutamic acid for calcium binding, 4) cell adhesion 
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SHED Alkaline Phosphatase Activity DPSC Alkaline Phosphatase Activity 
(A) Quantitative cell proliferation assay revealed higher proliferation rates for SHED as 
compared to DPSC, a slight increase for cells treated with P-glycerophosphate + 
dexamethasone, the opposite effect with potassium phosphate + dexamethasone. (B) 
Alkaline phosphatase activity in SHED is increased with 3-glycerophosphate + 
dexamethasone, but reduced with potassium phosphate + dexamethasone compared to the 
control, again DPSC shows the contrary. 
Columns show mean values of triplicates, and error bars indicate standard deviation. 
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Gene expression profile of SHED and DPSC after 4 weeks of osteogenic induction. Data 
obtained from controls were set to 1 as indicated by the dotted line. The graph shows the 
fold-increase of gene expression compared to control cells cultured in media without 
osteogenic supplements. Columns display the mean values and error bars the standard 
deviation of three measurements. (A) SHED cultured with BGP + dex mainly increased the 
expression of genes involved in matrix deposition (Col I and III) and scaffold degradation and 
remodeling (MMP-2). Levels of ALP as an early marker of mineralization were elevated. 
Genes involved in the actual mineralization process, such as Runx2, Bsp and Oc were higher 
in cells cultured with potassium phosphate + dex. (B) DPSC cells show increase of collagen 
expression to a lesser extent than SHED. When cultured with potassium phosphate + dex, 
mineralization markers ALP, Bsp, and Oc are markedly upregulated and about two-fold 
higher than in SHED cultured under the same conditions. Dspp, a dentin-specific marker 
gene, ceases to be expressed. 
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FIGURE 4 
(A) SHED cultured with 0GP + dex form cell clusters and degrade the gel (arrows, pa = 
peptide amphiphile gel (H&E). (B) SHEDs show a fibroblast-like cell morphology and deposit 
a collagenous matrix (Masson's trichrome). (C) DPSC cultured with potassium phosphate + 
dex adopt an osteoblast-like phenotype, produce collagen localized around cells (Masson's 
trichrome) and (D) deposit mineral (von Kossa stain). 
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FIGURE 5 
cryoTEM images show mineral deposition only for cells treated with osteogenic 
supplements after four weeks in culture. Whereas SHED cells produce few deposits, DPSC 
exhibit a much higher tendency for mineralization. Treatment with potassium phosphate + 
dex enhances mineral deposition significantly. (A) SHED control, (B) SHED cultured with 0GP 
and dex, (C) SHED cultured with KPh + dex, (D) DPSC control, (E) DPSC cultured with PGP + 
dex, (F) DPSC cultured with KPh + dex. 
134 
REFERENCES 
1. Miura, M., Gronthos, S., Zhao, M.; Lu, B., Fisher, L.W., Robey, P.G., and Shi, S. SHED: 
Stem cells from human exfoliated deciduous teeth. PNAS 100, 5808, 2003. 
2. Gronthos, S., Brahim, J., Li, W., Fisher, L.W., Cherman, N., Boyde, A., DenBesten, P., 
Robey PG, and Shi S. Stem cell properties of human dental pulp stem cells. J Dent Res 
81, 531, 2002. 
3. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and Shi, S. Postnatal human dental 
pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97,13625, 2000. 
4. Seo, B.M., Miura, M., Gronthos, S., Bartold, P.M., Batouli, S., Brahim, J., Young, M., 
Robey, P.G., Wang, C.Y., and Shi, S. Investigation of multipotent postnatal stem cells 
from human periodontal ligament. Lancet 364, 149, 2004. 
5. Jo, Y.Y., Lee, H.J., Kook, S.Y., Choung, H.W., Park, J.Y., Chung, J.H., Choung, Y.H., Kim, 
E.S., Yang, H.C., and Choung, P.H. Isolation and characterization of postnatal stem cells 
from human dental tissues. Tissue Eng 13, 767, 2007. 
6. Morsczeck, C, Schmalz, G., Reichert, T.E., Vollner, F., Galler, K., and Driemel, O. Dental 
stem cells for regenerative medicine. Clin Oral Invest. In press. 
7. Hartgerink, J.D., Beniash, E., and Stupp, I.S. Self-assembly and mineralization of peptide 
amphiphile nanofibers. Science 294,1684, 2001. 
8. Hartgerink, J.D., Beniash, E., and Stupp, I.S. Peptide-amphiphile nanofibers: A versatile 
scaffold for the preparation of self-assembling materials. Proc Natl Acad Sci USA 99, 
5133, 2002. 
9. Beniash, E., Hartgerink, J.D., Storrie, H., Stendahl, L.C., and Stupp, S.I. Self-assembling 
peptide amphiphile nanofiber matrices for cell entrapment. Acta Biomater 1, 387, 2005. 
10. Jun, H.W., Yuwono, V., Paramonov, S.E., and Hartgerink, J. Enzyme-mediated 
degradation of peptide-amphiphile nanofiber networks. Adv. Mater 17, 2612, 2005. 
11. Harrington, D.A., Cheng, E.Y., Guler, M.O., Lee, L.K., Donovan, J.L., Claussen, R.C., and 
Stupp, S.I. Branched peptide-amphiphiles as self-assembling coatings for tissue 
engineering scaffolds. J Biomed Mater Res A 78,157, 2006. 
135 
12. Rajangam, K., Behanna, H.A., Hui, M.J., Han, X., Hulvat, J.F., Lomasney, J.W., and Stupp, 
S.I. Heparin binding nanostructures to promote growth of blood vessels. Nano Lett 6, 
2086, 2006. 
13. Paramonov, S.E., Jun, H.E., and Hartgerink, J.D. Self-assembly of peptide-amphiphile 
nanofibers: The roles of hydrogen bonding and amphiphilic packing. J Am Chem Soc 128, 
7291, 2006. 
14. Silva, G.A., Czeisler, C, Niece, K.L., Beniash, E., Harrington, D.A., Kessler, J.A., and Stupp, 
S.I. Selective differentiation of neural progenitor cells by high-epitope density 
nanofibers. Science 303,1352, 2004. 
15. Hosseinkhani, H., Hosseinkhani, M., Tian, F., Kobayashi, H., and Tabata, Y. Osteogenic 
differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile 
nanofibers. Biomaterials 27, 4079, 2006. 
16. Hartgerink, J.D. Covalent capture: a natural complement to self-assembly. Curr Opin 
Chem Biol 8, 604, 2004. 
17. Guler, M.O., Hsu, L., Soukasene, S., Harrington, D.A., Hulvat, J.F., and Stupp, S.I. 
Presentation of RGDS epitopes on self-assembled nanofibers of branched peptide 
amphiphiles. Biomacromolecules 7,1855, 2006. 
18. Ruoslahti, E. and Pierschbacher, M.D. New perspectives in cell adhesion: RGD and 
integrins. Science 23, 491,1987. 
19. Huang, F.M., Yang, S.F., Hsieh, Y.S., Liu, CM., Yang, L.C., and Chang, Y.C. Examination of 
the signal transduction pathways involved in matrix metalloproteinases-2 in human pulp 
cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97, 398, 2004. 
20. Gronthos, S., Graves, S.E., Ohta, S., and Simmons, P.J. The STRO-1+ fraction of adult 
human bone marrow contains the osteogenic precursors. Blood 84, 4164,1994. 
21. Zhang, W., Walboomers, X.F., van Kuppevelt, T.H., Daamen, W.F., Bian, Z., and Jansen, 
J.A. The performance of human dental pulp stem cells on different three-dimensional 
scaffold materials. Biomaterials 27, 5658, 2006. 
136 
22. Garreta, E., Genove, E., Borros, S., and Semino, C.E. Osteogenic differentiation of mouse 
embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-
assembling peptide scaffold. Tissue Eng 12, 2215, 2006. 
23. Ranley, D.M. and Garcia-Godoy, F. Current and potential pulp therapies for primary and 
young permanent teeth. J Dent Res 28,153, 2000. 
24. Olsson, H., Petersson, K., and Rohlin, M. Formation of hard tissue barrier after pulp 
cappings in humans. A systematic review. Int Endod J 39, 429, 2006. 
25. Alliot-Licht, B., Bluteau, G., Magne, D., Lopez-Cazaux, S., Lieubeau, B., Daculsi, G., and 
Guicheux, J. Dexamethasone stimulates differentiation of odontoblast-like cells in 
human dental pulp cultures. Cell Tissue Res 321, 391, 2005. 
26. Deng, M., Shi, J., Smith, A.J., and Jin, Y. Effects of transforming growth factor betal 
(TGFbeta-1) and dentin non-collagenous proteins (DNCP) on human embryonic 
ectomesenchymal cells in a three-dimensional culture system. Arch Oral Biol 50, 937, 
2005. 
27. Almushayt, A., Narayanan, K., Zaki, A.E., and George, A. Dentin matrix protein 1 induces 
cytodifferentiation of dental pulp stem cells into odontoblasts. Gene Ther 13, 611, 2006. 
28. Nakashima, M. Tissue engineering in endodontics. Aust Endod J 31, 111, 2005. 
137 
APPENDIX C 
Table 4: Primers for real-time PCR 
Primer 







































GAG TCA ACG GAT TTG GTC GT 
GAC AAG CTT CCC GTT CTG AG 
AAA AGG AAG CTT GGT CCA CT 
GTGTGG AGA AAG GAG CAG AA 
GGG AAC AAC TTG ATG GTG CT 
CCT CCT TCA ACA GCT TCC TG 
CCA CGT CTT CAC ATT TGG TG 
AGA CTG CGC CTG GTA GTT GT 
GTG GAT GAA AAC GAA CAA GG 
CCC CTT CTT CTC CAT TGT CT 
ACT GTG ACG AGT TGG CTG AC 
CAA GGG CAA GAG GAA AGA AG 
GAA CTG GGC CCT TTT TCA GA 
GCG GAA GCA TTC TGG AAG GA 
TTA AAT GCC AGT GGA ACC AT 
ATT CCC TTC TCC CTT GTG AC 
TGA GAT CTG CAA ACA GGA CA 
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APPENDIX E 
Table 6: Rheometry Data Stress Sweep 
Peptide 
K2(SL)6K2 
K2(SL)6K2_w/o sucrose, no PBS 








K2(SL)6K2 2w% + hep 5mg/mL 
K2(SL)6K2 l w % + hep 2.5mg/mL 
K2(SL)6K2 l w % + hep 1.25mg/mL 
K(SL)3RG(SL)3KGRGDS lw% + hep lmg/mL + PBS 




Col 1 (1.0 mg/mL) 
Col 1 (2.0 mg/mL) 
Col 1 (2.5 mg/mL) 
Col 1 (3.0 mg/mL) 
Col 1 (3.2 mg/mL) 

























































0.01 -1000 Pa 
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